# EDGAR Filing Document

**Accession Number:** 0001819796
**File Stem:** 0001819796-25-000018
**Filing Date:** 2025-8
**Character Count:** 218515
**Document Hash:** 518194aa5fea7a8844528a7cc631d091
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001819796-25-000018.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001819796-25-000018

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 96

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GCM Grosvenor Inc.
- **CENTRAL INDEX KEY:** 0001819796
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39716
- **FILM NUMBER:** 251194202

**BUSINESS ADDRESS:**
- **STREET 1:** 900 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 1100
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** 312-506-6500

**MAIL ADDRESS:**
- **STREET 1:** 900 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 1100
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611

?xml version='1.0' encoding='ASCII'? gcm-20250630

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**__________________________________**

**FORM 10-Q**

**__________________________________**

**(Mark One)**

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 30, 2025**

**OR**

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from to** 

**Commission file number 001-39716** 

**__________________________________**

**GCM Grosvenor Inc.**

(Exact Name of Registrant as Specified in Its Charter)

**__________________________________**

---

| | |
|:---|:---|
| **Delaware** | **85-2226287** |
| (State or Other Jurisdiction of Incorporation or Organization) | (IRS Employer Identification No.) |
| **900 North Michigan Avenue, Suite 1100** <br>**Chicago, IL** | **60611** |
| (Address of principal executive offices) | (Zip Code) |

---

**312-506-6500**

(Registrant's telephone number, including area code)

**N/A**

(Former Name, Former Address and Former Fiscal Year if Changed Since Last Report)

**__________________________________**

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Class A common stock, $0.0001 par value per share | GCMG | The Nasdaq Stock Market LLC |
| Warrants to purchase shares of Class A common stock | GCMGW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of August 4, 2025, there were 53,220,319 shares of the registrant's Class A common stock, par value $0.0001 per share, outstanding and 141,665,831 shares of the registrant's Class C common stock, par value $0.0001 per share, outstanding.

------

**<u>**Table of Contents**</u>**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| <u>[Part I - Financial Information](#ia8d1edb8b8d54a02a6cc38923a5581b8_10)</u> | <u>[Part I - Financial Information](#ia8d1edb8b8d54a02a6cc38923a5581b8_10)</u> |  |
| Item 1. | <u>[Financial Statements (unaudited)](#ia8d1edb8b8d54a02a6cc38923a5581b8_13)</u> | <u>[4](#ia8d1edb8b8d54a02a6cc38923a5581b8_13)</u> |
|  | <u>[Condensed Consolidated Statements of Financial Condition as of June 30, 2025 and December 31, 2024](#ia8d1edb8b8d54a02a6cc38923a5581b8_16)</u> | <u>[4](#ia8d1edb8b8d54a02a6cc38923a5581b8_16)</u> |
|  | <u>[Condensed Consolidated Statements of Income (Loss) for the Three and Six Months Ended June 30, 2025 and 2024](#ia8d1edb8b8d54a02a6cc38923a5581b8_19)</u> | <u>[5](#ia8d1edb8b8d54a02a6cc38923a5581b8_19)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Six Months Ended June 30, 2025 and 2024](#ia8d1edb8b8d54a02a6cc38923a5581b8_22)</u> | <u>[6](#ia8d1edb8b8d54a02a6cc38923a5581b8_22)</u> |
|  | <u>[Condensed Consolidated Statements of Equity (Deficit) for the Three and Six Months Ended June 30, 2025 and 2024](#ia8d1edb8b8d54a02a6cc38923a5581b8_25)</u> | <u>[7](#ia8d1edb8b8d54a02a6cc38923a5581b8_25)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows for the](#ia8d1edb8b8d54a02a6cc38923a5581b8_28)[Six Months Ended June 30, 2025 and 2024](#ia8d1edb8b8d54a02a6cc38923a5581b8_28)</u> | <u>[9](#ia8d1edb8b8d54a02a6cc38923a5581b8_28)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements](#ia8d1edb8b8d54a02a6cc38923a5581b8_31)</u> | <u>[10](#ia8d1edb8b8d54a02a6cc38923a5581b8_31)</u> |
| [Item](#ia8d1edb8b8d54a02a6cc38923a5581b8_103)2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ia8d1edb8b8d54a02a6cc38923a5581b8_103)</u> | <u>[32](#ia8d1edb8b8d54a02a6cc38923a5581b8_103)</u> |
| [Item](#ia8d1edb8b8d54a02a6cc38923a5581b8_136)3. | <u>[Quantitative and Qualitative Disclosures about Market Risk](#ia8d1edb8b8d54a02a6cc38923a5581b8_136)</u> | <u>[52](#ia8d1edb8b8d54a02a6cc38923a5581b8_136)</u> |
| [Item](#ia8d1edb8b8d54a02a6cc38923a5581b8_139) 4. | <u>[Controls and Procedures](#ia8d1edb8b8d54a02a6cc38923a5581b8_139)</u> | <u>[52](#ia8d1edb8b8d54a02a6cc38923a5581b8_139)</u> |
| <u>[Part II - Other Information](#ia8d1edb8b8d54a02a6cc38923a5581b8_142)</u> | <u>[Part II - Other Information](#ia8d1edb8b8d54a02a6cc38923a5581b8_142)</u> |  |
| [Item](#ia8d1edb8b8d54a02a6cc38923a5581b8_145)1. | <u>[Legal Proceedings](#ia8d1edb8b8d54a02a6cc38923a5581b8_145)</u> | <u>[53](#ia8d1edb8b8d54a02a6cc38923a5581b8_145)</u> |
| [Item 1A](#ia8d1edb8b8d54a02a6cc38923a5581b8_148). | <u>[Risk Factors](#ia8d1edb8b8d54a02a6cc38923a5581b8_148)</u> | <u>[53](#ia8d1edb8b8d54a02a6cc38923a5581b8_148)</u> |
| Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#ia8d1edb8b8d54a02a6cc38923a5581b8_151)</u> | <u>[53](#ia8d1edb8b8d54a02a6cc38923a5581b8_151)</u> |
| Item 3. | <u>[Defaults Upon Senior Securities](#ia8d1edb8b8d54a02a6cc38923a5581b8_154)</u> | <u>[53](#ia8d1edb8b8d54a02a6cc38923a5581b8_154)</u> |
| Item 4. | <u>[Mine Safety Disclosures](#ia8d1edb8b8d54a02a6cc38923a5581b8_157)</u> | <u>[53](#ia8d1edb8b8d54a02a6cc38923a5581b8_157)</u> |
| Item 5. | <u>[Other Information](#ia8d1edb8b8d54a02a6cc38923a5581b8_160)</u> | <u>[53](#ia8d1edb8b8d54a02a6cc38923a5581b8_160)</u> |
| [Item](#ia8d1edb8b8d54a02a6cc38923a5581b8_166)6. | <u>[Exhibits](#ia8d1edb8b8d54a02a6cc38923a5581b8_166)</u> | <u>[54](#ia8d1edb8b8d54a02a6cc38923a5581b8_166)</u> |
| <u>[Signatures](#ia8d1edb8b8d54a02a6cc38923a5581b8_169)</u> | <u>[Signatures](#ia8d1edb8b8d54a02a6cc38923a5581b8_169)</u> | <u>[55](#ia8d1edb8b8d54a02a6cc38923a5581b8_169)</u> |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

**BASIS OF PRESENTATION**

As used in this Quarterly Report on Form 10-Q, unless as the context requires otherwise, as used herein, references to "GCM," the "Company," "we," "us," and "our," and similar references refer collectively to GCM Grosvenor Inc. and its consolidated subsidiaries.

Unless the context otherwise requires, references in this Quarterly Report on Form 10-Q to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "AUM" are to assets under management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "CF Sponsor" are to CF Finance Holdings, LLC, a Delaware limited liability company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "clients" are to persons who invest in our funds, even if such persons are not deemed clients of our registered investment adviser subsidiaries for purposes of the Investment Advisers Act 1940, as amended;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Class A common stock" are to our Class A common stock, par value $0.0001 per share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Class B common stock" are to our Class B common stock, par value $0.0001 per share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Class C common stock" are to our Class C common stock, par value $0.0001 per share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "FPAUM" are to fee-paying AUM;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "GCMG" are to GCM Grosvenor Inc., which was incorporated in Delaware as a wholly owned subsidiary of Grosvenor Capital Management Holdings, LLLP, formed for the purpose of completing the Transaction. Pursuant to the Transaction, Grosvenor Capital Management Holdings, LLLP cancelled its shares in GCM Grosvenor Inc. no longer making GCM Grosvenor Inc. a wholly owned subsidiary of Grosvenor Capital Management Holdings, LLLP;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "GCM Grosvenor" are to GCMH, its subsidiaries, and GCM, L.L.C.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "GCM V" are to GCM V, LLC, a Delaware limited liability company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "GCMH" are to Grosvenor Capital Management Holdings, LLLP, a Delaware limited liability limited partnership;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "GCM Funds" and "our funds" are to GCM Grosvenor's specialized funds and customized separate accounts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "GCMH Equityholders" are to Holdings, Management LLC, Holdings II and GCM Progress Subsidiary LLC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Grosvenor common units" are to units of partnership interests in GCMH entitling the holder thereof to the distributions, allocations, and other rights accorded to holders of partnership interests in GCMH;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Holdings" are to Grosvenor Holdings, L.L.C., an Illinois limited liability company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Holdings II" are to Grosvenor Holdings II, L.L.C., a Delaware limited liability company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "IntermediateCo" are to GCM Grosvenor Holdings, LLC (formerly known as CF Finance Intermediate Acquisition, LLC), a Delaware limited liability company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Management LLC" are to GCM Grosvenor Management, LLC, a Delaware limited liability company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "NAV" are to net asset value;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Sunset Date" are to the date the GCMH Equityholders beneficially own a number of voting shares representing less than 20% of the number of shares of Class A common stock beneficially owned by the GCMH Equityholders immediately following the Closing Date (assuming, for this purpose, that all outstanding Grosvenor common units are and were exchanged at the applicable measurement time by the GCMH Equityholders for shares of Class A common stock in accordance with the A&R LLLPA and without regard to the lock-up or any other restriction on exchange);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "Transaction" are to the transactions contemplated by the definitive transaction agreement, dated as of August 2, 2020, by and among CF Finance Acquisition Corp., a Delaware corporation, IntermediateCo, CF Finance Holdings, LLC, a Delaware limited liability company, GCMH, the GCMH Equityholders, GCMH GP, L.L.C., GCM V and us; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• "TRA Parties" are to the GCMH LLLP Equityholders, and their successors and assigns with respect to the Tax Receivable Agreement ("TRA").

------

**FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including, but not limited to, statements regarding our future results of operations or financial condition; business strategy and plans; including anticipated and future payments of dividends and capital return plans; market opportunity and changes in investor perceptions of alternative investments; our ability to expand our product offerings for certain investors; and our relationships with our existing clients as part of our growth strategies may be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "forecasts," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to statements regarding our future results of operations and financial position, industry and business trends, equity compensation, business strategy, plans, market growth and our objectives for future operations.

The forward-looking statements in this Quarterly Report on Form 10-Q are only current expectations and predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the historical performance of GCM Grosvenor's funds may not be indicative of GCM Grosvenor's future results; risks related to redemptions and termination of engagements; the variable nature of GCM Grosvenor's revenues; competition in GCM Grosvenor's industry; effects of government regulation or compliance failures, including in regards to new and changing regulations; market, geopolitical and economic conditions, identification and availability of suitable investment opportunities; risks related to the performance of GCM Grosvenor's investments; and the other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the Securities and Exchange Commission. The forward-looking statements in this Quarterly Report on Form 10-Q are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should read this Quarterly Report on Form 10-Q and the documents that we reference in this Quarterly Report on Form 10-Q and have filed as exhibits to this Quarterly Report on Form 10-Q with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this Quarterly Report on Form 10-Q.

------

**PART I - FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS** 

**GCM Grosvenor Inc.**

**Condensed Consolidated Statements of Financial Condition**

***(In thousands, except share and per share amounts)***

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| | **June 30, 2025** | **December 31, 2024** |
| | **(Unaudited)** | |
| **Assets** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $136334 | $89454 |
| &nbsp;&nbsp;&nbsp;&nbsp;Management fees receivable | 22696 | 28387 |
| &nbsp;&nbsp;&nbsp;&nbsp;Incentive fees receivable | 20915 | 58346 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due from related parties | 13976 | 12681 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments | 262755 | 257807 |
| &nbsp;&nbsp;&nbsp;&nbsp;Premises and equipment, net | 23804 | 22683 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease right-of-use assets | 41294 | 41146 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 657 | 1314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 28959 | 28959 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax assets, net | 60910 | 51160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 24559 | 20794 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | 636859 | 612731 |
| **Liabilities and Equity (Deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and employee related obligations | 60782 | 112519 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt | 430235 | 432039 |
| &nbsp;&nbsp;&nbsp;Payable to related parties pursuant to the tax receivable agreement | 60599 | 51429 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease liabilities | 53569 | 53876 |
| &nbsp;&nbsp;&nbsp;&nbsp;Warrant liabilities | 11280 | 22510 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | 41033 | 30697 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 657498 | 703070 |
| Commitments and contingencies (Note 13) |  |  |
| Preferred stock, $0.0001 par value, 100,000,000 shares authorized, none issued |  |  |
| Class A common stock, $0.0001 par value, 700,000,000 authorized; 53,217,309 and 44,899,246 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 5 | 4 |
| Class B common stock, $0.0001 par value, 500,000,000 authorized, none issued |  |  |
| Class C common stock, $0.0001 par value, 300,000,000 authorized; 141,665,831 and 144,235,246 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 14 | 14 |
| Additional paid-in capital | 18953 | 5752 |
| Accumulated other comprehensive income | 48 | 1650 |
| Retained earnings | (31309) | (35040) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total GCM Grosvenor Inc. deficit | (12289) | (27620) |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests in subsidiaries | 46749 | 52233 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests in GCMH | (55099) | (114952) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total deficit | (20639) | (90339) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity (deficit) | $636859 | $612731 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

See accompanying notes to Condensed Consolidated Financial Statements.

------

**GCM Grosvenor Inc.**

**Condensed Consolidated Statements of Income (Loss)**

**(Unaudited)**

***(In thousands, except share and per share amounts)***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Revenues** |  |  |  |  |
| Management fees | $101924 | $99843 | $211239 | $195728 |
| Incentive fees | 16258 | 16037 | 31326 | 26155 |
| Other operating income | 1475 | 1074 | 2938 | 3937 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating revenues | 119657 | 116954 | 245503 | 225820 |
| **Expenses** |  |  |  |  |
| Employee compensation and benefits | 74863 | 67955 | 157103 | 167602 |
| General, administrative and other | 25549 | 28164 | 53825 | 53343 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 100412 | 96119 | 210928 | 220945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 19245 | 20835 | 34575 | 4875 |
| Investment income | 5782 | 1290 | 6546 | 6967 |
| Interest expense | (5908) | (6134) | (11571) | (12057) |
| Other income | 1182 | 394 | 2028 | 947 |
| Change in fair value of warrant liabilities | 19388 | (180) | 10612 | (2324) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net other income (expense) | 20444 | (4630) | 7615 | (6467) |
| Income (loss) before income taxes | 39689 | 16205 | 42190 | (1592) |
| Provision (benefit) for income taxes | (202) | 3244 | 3389 | 4354 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | 39891 | 12961 | 38801 | (5946) |
| Less: Net income (loss) attributable to noncontrolling interests in subsidiaries | 980 | (901) | 1155 | 401 |
| Less: Net income (loss) attributable to noncontrolling interests in GCMH | 23474 | 9062 | 21746 | (13271) |
| &nbsp;&nbsp;&nbsp;Net income attributable to GCM Grosvenor Inc. | $15437 | $4800 | $15900 | $6924 |
| **Earnings (loss) per share of Class A common stock:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $0.30 | $0.11 | $0.33 | $0.16 |
| &nbsp;&nbsp;&nbsp;Diluted | $0.05 | $0.04 | $0.07 | $(0.08) |
| **Weighted average shares of Class A common stock outstanding:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 51074156 | 44934623 | 48367585 | 44302442 |
| &nbsp;&nbsp;&nbsp;Diluted | 196338595 | 190178273 | 195641160 | 188537688 |

---

See accompanying notes to Condensed Consolidated Financial Statements.

------

**GCM Grosvenor Inc.**

**Condensed Consolidated Statements of Comprehensive Income (Loss)**

**(Unaudited)**

***(In thousands)***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;Net income (loss) | $39891 | $12961 | $38801 | $(5946) |
| **Other comprehensive income (loss), net of tax:** |  |  |  |  |
| Net change in cash flow hedges | (4169) | (2585) | (10879) | 616 |
| Foreign currency translation adjustment | 997 | (503) | 1727 | (1181) |
| &nbsp;&nbsp;Total other comprehensive loss | (3172) | (3088) | (9152) | (565) |
| &nbsp;&nbsp;Comprehensive income (loss) before noncontrolling interests | 36719 | 9873 | 29649 | (6511) |
| Less: Comprehensive income (loss) attributable to noncontrolling interests in subsidiaries | 980 | (901) | 1155 | 401 |
| Less: Comprehensive income (loss) attributable to noncontrolling interests in GCMH | 20808 | 6517 | 14196 | (13636) |
| &nbsp;&nbsp;Comprehensive income attributable to GCM Grosvenor Inc. | $14931 | $4257 | $14298 | $6724 |

---

See accompanying notes to Condensed Consolidated Financial Statements.

------

**GCM Grosvenor Inc.**

**Condensed Consolidated Statements of Equity (Deficit)** 

**(Unaudited)**

***(In thousands)***

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A Common Stock** | **Class C Common Stock** | **Additional <br>Paid-in <br>Capital** | **Retained <br>Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Noncontrolling Interests in Subsidiaries** | **Noncontrolling Interests in GCMH** | **Total Equity (Deficit)** |
| **Balance at March 31, 2025** | $4 | $14 | $11786 | $(40683) | $554 | $47480 | $(108829) | $(89674) |
| Capital contributions from noncontrolling interests in subsidiaries |  |  |  |  |  | 978 |  | 978 |
| Capital distributions paid to noncontrolling interests |  |  |  |  |  | (2689) |  | (2689) |
| Issuance of Class A common stock due to exercised warrants |  |  |  |  |  |  |  |  |
| Settlement of equity-based compensation in satisfaction of withholding tax requirements |  |  | (3906) |  |  |  | (11230) | (15136) |
| Partners' distributions |  |  |  |  |  |  | (19242) | (19242) |
| Deemed contributions |  |  |  |  |  |  | 16323 | 16323 |
| Proceeds from Share Purchase Agreement | 1 |  | 12635 |  |  |  | 37197 | 49833 |
| Exchange of Partnership units for Class A common stock |  |  | (1420) |  |  |  | 1419 | (1) |
| Net change in cash flow hedges |  |  |  |  | (757) |  | (3412) | (4169) |
| Translation adjustment |  |  |  |  | 251 |  | 746 | 997 |
| Equity-based compensation, equity-classified awards |  |  | 1888 |  |  |  | 5358 | 7246 |
| Declared dividends |  |  |  | (6320) |  |  |  | (6320) |
| Deferred tax and other tax adjustments |  |  | 1324 |  |  |  |  | 1324 |
| Equity reallocation between controlling and non-controlling interests |  |  | (3354) | 257 |  |  | 3097 |  |
| Net income (loss) |  |  |  | 15437 |  | 980 | 23474 | 39891 |
| **Balance at June 30, 2025** | $5 | $14 | $18953 | $(31309) | $48 | $46749 | $(55099) | $(20639) |
|  | **Class A Common Stock** | **Class C Common Stock** | **Additional <br>Paid-in <br>Capital** | **Retained <br>Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Noncontrolling Interests in Subsidiaries** | **Noncontrolling Interests in GCMH** | **Total Equity (Deficit)** |
| **Balance at December 31, 2024** | $4 | $14 | $5752 | $(35040) | $1650 | $52233 | $(114952) | $(90339) |
| Capital contributions from noncontrolling interests in subsidiaries |  |  |  |  |  | 1238 |  | 1238 |
| Capital distributions paid to noncontrolling interests |  |  |  |  |  | (7877) |  | (7877) |
| Issuance of Class A common stock due to exercised warrants |  |  | 806 |  |  |  | 2575 | 3381 |
| Settlement of equity-based compensation in satisfaction of withholding tax requirements |  |  | (3980) |  |  |  | (11468) | (15448) |
| Partners' distributions |  |  |  |  |  |  | (38306) | (38306) |
| Deemed contributions |  |  |  |  |  |  | 28548 | 28548 |
| Proceeds from Share Purchase Agreement, net | 1 |  | 12635 |  |  |  | 37197 | 49833 |
| Exchange of Partnership units for Class A common stock |  |  | (1420) |  |  |  | 1419 | (1) |
| Net change in cash flow hedges |  |  |  |  | (2027) |  | (8852) | (10879) |
| Translation adjustment |  |  |  |  | 425 |  | 1302 | 1727 |
| Equity-based compensation, equity-classified awards |  |  | 7209 |  |  |  | 22338 | 29547 |
| Declared dividends |  |  |  | (12169) |  |  |  | (12169) |
| Deferred tax and other tax adjustments |  |  | 1305 |  |  |  |  | 1305 |
| Equity reallocation between controlling and non-controlling interests |  |  | (3354) |  |  |  | 3354 |  |
| Net income (loss) |  |  |  | 15900 |  | 1155 | 21746 | 38801 |
| **Balance at June 30, 2025** | $5 | $14 | $18953 | $(31309) | $48 | $46749 | $(55099) | $(20639) |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Class A Common Stock** | **Class C Common Stock** | **Additional <br>Paid-in <br>Capital** | **Retained <br>Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Noncontrolling Interests in Subsidiaries** | **Noncontrolling Interests in GCMH** | **Total Equity (Deficit)** |
| **Balance at March 31, 2024** | $4 | $14 | $4817 | $(34201) | $2973 | $57588 | $(132066) | $(100871) |
| Capital contributions from noncontrolling interests in subsidiaries |  |  |  |  |  | 402 |  | 402 |
| Capital distributions paid to noncontrolling interests |  |  |  |  |  | (2778) |  | (2778) |
| Settlement of equity-based compensation in satisfaction of withholding tax requirements |  |  | (2358) |  |  |  | (7807) | (10165) |
| Partners' distributions |  |  |  |  |  |  | (7969) | (7969) |
| Deemed contributions |  |  |  |  |  |  | 11588 | 11588 |
| Net change in cash flow hedges |  |  |  |  | (426) |  | (2159) | (2585) |
| Translation adjustment |  |  |  |  | (117) |  | (386) | (503) |
| Equity-based compensation, equity-classified awards |  |  | 2763 |  |  |  | 9126 | 11889 |
| Declared dividends |  |  |  | (5506) |  |  |  | (5506) |
| Deferred tax and other tax adjustments |  |  | (170) |  |  |  |  | (170) |
| Equity reallocation between controlling and non-controlling interests |  |  |  | (1092) |  |  | 1092 |  |
| Net income (loss) |  |  |  | 4800 |  | (901) | 9062 | 12961 |
| **Balance at June 30, 2024** | $4 | $14 | $5052 | $(35999) | $2430 | $54311 | $(119519) | $(93707) |
|  | **Class A Common Stock** | **Class C Common Stock** | **Additional <br>Paid-in <br>Capital** | **Retained <br>Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Noncontrolling Interests in Subsidiaries** | **Noncontrolling Interests in GCMH** | **Total Equity (Deficit)** |
| **Balance at December 31, 2023** | $4 | $14 | $1936 | $(32218) | $2630 | $59757 | $(143352) | $(111229) |
| Capital contributions from noncontrolling interests in subsidiaries |  |  |  |  |  | 798 |  | 798 |
| Capital distributions paid to noncontrolling interests |  |  |  |  |  | (6645) |  | (6645) |
| Settlement of equity-based compensation in satisfaction of withholding tax requirements |  |  | (2392) |  |  |  | (7922) | (10314) |
| Partners' distributions |  |  |  |  |  |  | (15865) | (15865) |
| Deemed contributions |  |  |  |  |  |  | 41590 | 41590 |
| Net change in cash flow hedges |  |  |  |  | 73 |  | 543 | 616 |
| Translation adjustment |  |  |  |  | (273) |  | (908) | (1181) |
| Equity-based compensation, equity-classified awards |  |  | 5984 |  |  |  | 19932 | 25916 |
| Declared dividends |  |  |  | (10971) |  |  |  | (10971) |
| Deferred tax and other tax adjustments |  |  | (476) |  |  |  |  | (476) |
| Equity reallocation between controlling and non-controlling interests |  |  |  | 266 |  |  | (266) |  |
| Net income (loss) |  |  |  | 6924 |  | 401 | (13271) | (5946) |
| **Balance at June 30, 2024** | $4 | $14 | $5052 | $(35999) | $2430 | $54311 | $(119519) | $(93707) |

---

See accompanying notes to Condensed Consolidated Financial Statements.

------

**GCM Grosvenor Inc.**

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)**

***(In thousands)***

---

| | | |
|:---|:---|:---|
| | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| Net income (loss) | $38801 | $(5946) |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization expense | 2161 | 1277 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity-based compensation, equity-classified awards | 29547 | 25916 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax expense | 1993 | 2867 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-cash compensation | 177 | 350 |
| &nbsp;&nbsp;&nbsp;&nbsp;Partnership interest-based compensation | 28548 | 41590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 386 | 508 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of terminated swap | (3760) | (3781) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  | 157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of warrant liabilities | (10612) | 2324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in payable to related parties pursuant to tax receivable agreement |  | 41 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds received from investments | 6837 | 3700 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash investment income | (6546) | (6967) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease expense | 1911 | 3734 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | (55) | 271 |
| Change in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Management fees receivable | 5864 | 3271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Incentive fees receivable | 37431 | 7150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due from related parties | (1277) | 4388 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | (3515) | (3581) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and employee related obligations | (52393) | (37321) |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease liabilities, net | (2408) | (1726) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | 2151 | 3460 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 75241 | 41682 |
| **Cash flows from investing activities** |  |  |
| Purchases of premises and equipment | (2392) | (8867) |
| Contributions/subscriptions to investments | (15056) | (12008) |
| Distributions from investments | 9817 | 4378 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (7631) | (16497) |
| **Cash flows from financing activities** |  |  |
| Capital contributions received from noncontrolling interests | 1238 | 798 |
| Capital distributions paid to partners and member | (38306) | (15865) |
| Capital distributions paid to noncontrolling interests | (7877) | (7095) |
| Proceeds from senior loan issuance |  | 50000 |
| Principal payments on senior loan | (2190) | (1000) |
| Debt issuance costs |  | (556) |
| Proceeds from exercise of warrants | 2762 |  |
| Settlement of equity-based compensation in satisfaction of withholding tax requirements | (15448) | (10314) |
| Proceeds from Share Purchase Agreement, net | 49833 |  |
| Dividends paid | (12064) | (10304) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | (22052) | 5664 |
| Effect of exchange rate changes on cash | 1322 | (1282) |
| Net increase in cash and cash equivalents | $46880 | $29567 |
| **Cash and cash equivalents** |  |  |
| Beginning of period | 89454 | 44354 |
| End of period | $136334 | $73921 |
| **Supplemental disclosure of cash flow information** |  |  |
| Cash paid during the period for interest | $14395 | $15858 |
| Cash paid during the period for income taxes, net | $5158 | $3426 |
| **Supplemental disclosure of cash flow information from operating activities** |  |  |
| Non-cash right-of-use assets obtained in exchange for new and modified operating leases | $1967 | $8953 |
| Non-cash adjustment to operating lease right-of-use assets from lease modification | $(102) | $(265) |
| **Supplemental disclosure of cash flow information from investing activities** |  |  |
| Non-cash premises and equipment additions in accrued expenses and other liabilities | $— | $1027 |
| **Supplemental disclosure of non-cash information from financing activities** |  |  |
| Deemed contributions from GCMH Equityholders | $28548 | $41590 |
| Establishment of deferred tax assets, net related to non-cash activities | $1305 | $(476) |
| Non-cash change in payable to related parties pursuant to tax receivable agreement | $9170 | $— |

---

See accompanying notes to Condensed Consolidated Financial Statements.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements**

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**1. Organization**

GCM Grosvenor Inc. ("GCMG") and its subsidiaries including Grosvenor Capital Management Holdings, LLLP (the "Partnership" or "GCMH" and collectively, the "Company"), provide comprehensive investment solutions to institutional and individual clients who seek allocations to alternative investments such as absolute return strategies, private equity, real estate, infrastructure and alternative credit. The Company collaborates with its clients to construct investment portfolios across multiple investment strategies in the private and public markets, often customized to meet their specific objectives. The Company also offers specialized commingled funds which span the alternatives investing universe and are developed to meet broad market demands for strategies and risk-return objectives.

The Company, through its subsidiaries acts as the investment adviser, general partner or managing member to customized funds and specialized funds (collectively, the "GCM Funds").

GCMG was incorporated on July 27, 2020 under the laws of the State of Delaware for the purpose of consummating the Transaction and merging with CF Finance Acquisition Corp. ("CFAC"), which was incorporated on July 9, 2014 under the laws of the State of Delaware. GCMG owns all of the equity interests of GCM Grosvenor Holdings, LLC ("IntermediateCo"), formerly known as CF Finance Intermediate Acquisition, LLC until November 18, 2020, which is the general partner of GCMH subsequent to the Transaction. GCMG's ownership (through IntermediateCo) of GCMH as of June 30, 2025 and December 31, 2024 was approximately 27.3% and 23.7%, respectively.

GCMH is a holding company operated pursuant to the Fifth Amended and Restated Limited Liability Limited Partnership Agreement (the "Partnership Agreement") dated November 17, 2020, among the limited partners including Grosvenor Holdings, L.L.C. ("Holdings"), Grosvenor Holdings II, L.L.C. ("Holdings II") and GCM Grosvenor Management, LLC ("Management LLC") (collectively, together with GCM Progress Subsidiary LLC, the "GCMH Equityholders").

**2. Summary of Significant Accounting Policies**

**Basis of Presentation**

The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. In the opinion of management, all necessary adjustments (which consists of only normal recurring items) have been made to fairly present the Condensed Consolidated Financial Statements for the interim periods presented. Results of operations for the three and six months ended June 30, 2025 are not necessarily indicative of the results that may be expected for the year ending December 31, 2025. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission ("SEC").

**Fair Value Measurements**

The Company categorizes its fair value measurements according to a three-level hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are defined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Inputs that are unobservable and require significant management judgment or estimation.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available under the circumstances.

The carrying amounts of cash and cash equivalents and fees receivable approximate fair value due to the immediate or short-term maturity of these financial instruments.

**Investments**

Investments primarily consist of investments in GCM Funds and other funds the Company does not control, but is deemed to exert significant influence, and are generally accounted for using the equity method of accounting. Under the equity method of accounting, the Company records its share of the underlying income or loss of such entities, which reflects the net asset value of such investments. Management believes the net asset value of the funds is representative of fair value. The resulting gains and losses are included as investment income in the Condensed Consolidated Statements of Income (Loss).

The Company's equity method investments in the GCM Funds investing in private equity, real estate and infrastructure ("GCM PEREI Funds"), are valued based on the most recent available information, which typically has a delay of up to three months due to the timing of financial information received from the investments held by the GCM PEREI Funds. The Company records its share of capital contributions to and distributions from the GCM PEREI Funds within investments in the Condensed Consolidated Statements of Financial Condition during the three-month lag period. To the extent that management is aware of material events that affect the GCM PEREI Funds during the intervening period, the impact of the events would be disclosed in the notes to the Condensed Consolidated Financial Statements.

Certain subsidiaries which hold the general partner capital interest in the GCM Funds are not wholly owned, and as such, the portion of the Company's investments owned by limited partners in those subsidiaries are reflected within noncontrolling interests in the Condensed Consolidated Statements of Financial Condition.

The Company holds an investment in an unconsolidated entity, which is accounted for using the equity method of accounting. The investment is recognized at cost, adjusted for the Company's share of the entity's net income or loss, less any distributions or dividends received by the Company and any impairment of the investment. The Company records its share of capital contributions to and distributions from its investment within investments in the Condensed Consolidated Statements of Financial Condition during the three-month lag period. The Company records its proportionate share of net income or loss from the investment as investment income on the Condensed Consolidated Statements of Income (Loss) on a one quarter lag. To the extent that management is aware of material events that affect its investment during the intervening period, the impact of the events would be disclosed in the notes to the Condensed Consolidated Financial Statements.

For certain other debt investments, the Company has elected the fair value option. Such election is irrevocable and is made at the investment level at initial recognition. The debt investments are not publicly traded and are a Level 3 fair value measurement. For investments carried at fair value, the Company records the increase or decrease in fair value as investment income in the Condensed Consolidated Statements of Income (Loss).

See Note 5 for additional information regarding the Company's other investments.

**Recently Issued Accounting Standards**

In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*. ASU 2023-09 requires enhanced income tax disclosures including disclosures of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold, additional disclosures about income taxes paid, and disclosure of pre-tax income or loss from continuing operations disaggregated between domestic and foreign income or loss. This guidance is effective for public business entities for annual periods beginning after December 15, 2024. Companies should provide the enhanced disclosures on a prospective basis, however retrospective application is permitted. Early adoption is permitted for annual financial statements that have not yet been issued. The Company is evaluating this guidance and currently expects that adoption will result in enhanced income tax disclosures.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

In November 2024, the FASB issued ASU 2024-03, *Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*. ASU 2024-03 requires public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

**3. Revenues**

For the three and six months ended June 30, 2025 and 2024, management fees and incentive fees consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| **Management fees** | **2025** | **2024** | **2025** | **2024** |
| Management fees, net | $97934 | $96497 | $202567 | $188449 |
| Fund expense reimbursement revenue | 3990 | 3346 | 8672 | 7279 |
| Total management fees | $101924 | $99843 | $211239 | $195728 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| **Incentive fees** | **2025** | **2024** | **2025** | **2024** |
| Performance fees | $1433 | $4346 | $5251 | $10333 |
| Carried interest | 14825 | 11691 | 26075 | 15822 |
| Total incentive fees | $16258 | $16037 | $31326 | $26155 |

---

The Company recognized revenues of $0.9 million during the six months ended June 30, 2025, and less than $0.1 million during the three months ended June 30, 2025 and each of the three and six months ended June 30, 2024, that was previously received and deferred at the beginning of the respective periods.

**4. Investments** 

Investments consist of the following:

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| | **June 30, 2025** | **December 31, 2024** |
| Equity method investments | $250100 | $245567 |
| Other investments | 12655 | 12240 |
| Total investments | $262755 | $257807 |

---

As of June 30, 2025 and December 31, 2024, the Company held investments of $262.8 million and $257.8 million, respectively, of which $43.6 million and $49.0 million were owned by noncontrolling interest holders, respectively. Net income (loss) and cash flow from investments held by noncontrolling interest holders will not be attributable to the Company.

On February 28, 2025, the Company closed a joint venture, Grove Lane Partners LLC ("Grove Lane"), a premier distribution platform to broaden individual investor access to alternative investments. Upon closing, the Company made a total capital commitment of $15.0 million in exchange for a 49% interest in Grove Lane, which we account for using the equity method of accounting. Under the terms of the joint venture agreement, the Company maintains the right, but not the obligation, to purchase the remaining 51% interest at a future date based on an agreed upon future value. As of June 30, 2025, the Company has funded $1.4 million of its capital commitment.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**Other Investments**

See Note 5 for fair value disclosures of certain investments held within other investments. The Company also holds $0.1 million and $0.2 million of other investments not held at fair value held within other investments as of June 30, 2025 and December 31, 2024.

**5. Fair Value Measurements**

The following table summarizes the Company's assets and liabilities measured at fair value on a recurring basis and level of inputs used for such measurements as of June 30, 2025 and December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value as of June 30, 2025** | **Fair Value as of June 30, 2025** | **Fair Value as of June 30, 2025** | **Fair Value as of June 30, 2025** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Assets** | | | | |
| Money market funds | $102851 | $— | $— | $102851 |
| Other investments |  |  | 12509 | 12509 |
| **Total assets** | $102851 | $— | $12509 | $115360 |
| **Liabilities** |  |  |  |  |
| Public warrants | $10589 | $— | $— | $10589 |
| Private warrants |  |  | 691 | 691 |
| Interest rate derivatives |  | 11450 |  | 11450 |
| **Total liabilities** | $10589 | $11450 | $691 | $22730 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value as of December 31, 2024** | **Fair Value as of December 31, 2024** | **Fair Value as of December 31, 2024** | **Fair Value as of December 31, 2024** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Assets** | | | | |
| Money market funds | $43804 | $— | $— | $43804 |
| Other investments |  |  | 11993 | 11993 |
| **Total assets** | $43804 | $— | $11993 | $55797 |
| **Liabilities** |  |  |  |  |
| Public warrants | $21149 | $— | $— | $21149 |
| Private warrants |  |  | 1361 | 1361 |
| Interest rate derivatives |  | 3532 |  | 3532 |
| **Total liabilities** | $21149 | $3532 | $1361 | $26042 |

---

**Money Market Funds**

Money market funds are valued using quoted market prices and are included in cash and cash equivalents in the Condensed Consolidated Statements of Financial Condition.

**Interest Rate Derivatives**

Management determines the fair value of its interest rate derivative agreements based on the present value of expected future cash flows based on observable future rates applicable to each swap contract using linear interpolation, inclusive of the risk of non-performance, using a discount rate appropriate for the duration. See Note 12 for additional information regarding interest rate derivatives.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**Other Investments**

Investments in the subordinated notes of a structured alternatives investment solution are not publicly traded and are classified as Level 3. Management determines the fair value of these other investments using a discounted cash flow analysis ("Cash Flow Analysis"), which includes assumptions regarding the expected deployment and realization timing of private investments. The position was classified as Level 3 as of June 30, 2025 and December 31, 2024 because of the use of significant unobservable inputs in the Cash Flow Analysis as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **June 30, 2025** | **December 31, 2024** | **December 31, 2024** | **Impact to Valuation from an Increase in Input**<sup>(2)</sup> |
|<br>**Significant Unobservable Inputs**<sup>(1)</sup> | **Range** | **Weighted Average** | **Range** | **Weighted Average** | **Impact to Valuation from an Increase in Input**<sup>(2)</sup> |
| Discount rate<sup>(3)</sup> | 25.5% – 27.5% | 26.5% | 25.8% - 27.8% | 26.8% | Decrease |
| Expected remaining term (years) | 7 – 11 | N/A | 8 – 12 | N/A | Decrease |
| Expected total value to paid in capital – private assets<sup>(4)</sup> | 1.55x – 2.10x | 1.87x | 1.55x – 2.13x | 1.87x | Increase |

---

____________

(1)In determining these inputs, management considers the following factors including, but not limited to: liquidity, estimated yield, capital deployment, diversified multi-strategy appreciation, expected net multiple of investment capital across private assets investments, annual operating expenses, as well as investment guidelines such as concentration limits, position size, and investment periods.

(2)Unless otherwise noted, this column represents the directional change in fair value of the Level 3 investments that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the opposite effect.

(3)The discount rate was based on the relevant benchmark rate, spread, and yield migrations on related securitized assets.

(4)Inputs were weighted based on actual and estimated commitments to the respective private asset investments included in the range.

The resulting fair values of $12.5 million and $12.0 million were recorded within investments in the Condensed Consolidated Statements of Financial Condition as of June 30, 2025 and December 31, 2024, respectively.

The following table presents changes in Level 3 assets measured at fair value for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Balance at beginning of period | $12341 | $11621 | $11993 | $11192 |
| &nbsp;&nbsp;&nbsp;Change in fair value | 168 | 158 | 516 | 587 |
| Balance at end of period | $12509 | $11779 | $12509 | $11779 |

---

**Public Warrants**

The public warrants are valued using quoted market prices on the Nasdaq Stock Market LLC under the ticker GCMGW.

**Private Warrants**

The private warrants were classified as Level 3 as of June 30, 2025 and December 31, 2024 because of the use of significant unobservable inputs in the valuation, however the overall private warrant valuation and change in fair value are not material to the Condensed Consolidated Financial Statements.

The valuations for the private warrants were determined to be $0.77 and $1.51 per unit as of June 30, 2025 and December 31, 2024, respectively. The resulting fair values of $0.7 million and $1.4 million were recorded within warrant liabilities in the Condensed Consolidated Statements of Financial Condition as of June 30, 2025 and December 31, 2024, respectively. See Note 7 for additional information regarding the warrant activity.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

The following table presents changes in Level 3 liabilities measured at fair value for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Balance at beginning of period | $1879 | $518 | $1361 | $389 |
| &nbsp;&nbsp;&nbsp;Change in fair value | (1188) | 11 | (670) | 140 |
| Balance at end of period | $691 | $529 | $691 | $529 |

---

**6. Equity** 

**Shares of Common Stock Outstanding** 

The following table shows a rollforward of the common stock outstanding for the three and six months ended June 30, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** |
| | **Class A common stock** | **Class B common stock** | **Class C common stock** | **Class A common stock** | **Class B common stock** | **Class C common stock** |
| Beginning of period | 45233791 |  | 144235246 | 44899246 |  | 144235246 |
| Exercise of warrants |  |  |  | 240190 |  |  |
| Issuance of Class A common stock | 3752965 |  |  | 3752965 |  |  |
| Net shares delivered for vested RSUs | 1661138 |  |  | 1755493 |  |  |
| Exchange of Partnership units for Class A common stock and cancellation of Class C common stock | 2569415 |  | (2569415) | 2569415 |  | (2569415) |
| End of period | 53217309 |  | 141665831 | 53217309 |  | 141665831 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Three Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** | **Six Months Ended June 30, 2024** |
| | **Class A common stock** | **Class B common stock** | **Class C common stock** | **Class A common stock** | **Class B common stock** | **Class C common stock** |
| Beginning of period | 42996776 |  | 144235246 | 42988563 |  | 144235246 |
| Net shares delivered for vested RSUs | 1563292 |  |  | 1571505 |  |  |
| End of period | 44560068 |  | 144235246 | 44560068 |  | 144235246 |

---

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

During the six months ended June 30, 2025, 240,190 public warrants were exercised resulting in $2.8 million of proceeds. No warrants were exercised during the three months ended June 30, 2025.

During the three months ended June 30, 2025, the Company entered into a Share Purchase Agreement with Sumitomo Mitsui Trust Bank, Limited ("SuMi Trust") for the issuance and sale in a registered direct offering of 3,752,965 shares of the Company's Class A common stock to SuMi Trust at an offering price of $13.322799 per share, which represented the 10-day volume-weighted average price of our Class A common stock ending March 31, 2025, for net proceeds of $49.8 million. The transaction was closed on April 22, 2025.

As of June 30, 2025, 318,217 RSUs were vested, but not yet delivered, and are therefore not yet included in outstanding Class A common stock. The delivery of vested RSUs will be reduced by the number of shares withheld to satisfy statutory withholding tax obligations as well as RSUs that are settled in cash. See Note 10 for additional information on the Company's RSUs.

During the three months ended June 30, 2025, the Company exchanged 2,569,415 Partnership common units for 2,569,415 shares of Class A common stock to deliver in settlement of the vested GCMH Equityholders Awards. At the same time, 2,569,415 shares of Class C common stock were cancelled. This conversion did not result in any cash transferred. As of June 30, 2025, 4,400,000 GCMH Equityholders Awards were vested, but not yet delivered, and are therefore not yet included in outstanding Class A common stock. See Note 9 for additional information on the Company's GCMH Equityholders Awards.

The Company records a reallocation adjustment between GCMG equity and Non-controlling interests in GCMH to reflect the impact of changes in economic ownership percentages during the respective period and adjust previously recorded equity transactions to the economic ownership percentage as of the end of each reporting period.

**Dividends**

Dividends are reflected in the Condensed Consolidated Statements of Equity (Deficit) when declared by the Board of Directors. The table below summarizes dividends declared to date during 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Declaration Date** | **Record Date** | **Payment Date** | **Dividend per Class A Common Share** |
| February 6, 2025 | March 3, 2025 | March 17, 2025 | $0.11 |
| May 5, 2025 | June 6, 2025 | June 16, 2025 | $0.11 |
| August 4, 2025 | September 2, 2025 | September 16, 2025 | $0.11 |

---

Dividend equivalent payments of $2.2 million were accrued for holders of RSUs as of June 30, 2025. Distributions to partners represent distributions made to GCMH Equityholders.

**Stock Repurchase Plan**

On August 6, 2021, GCMG's Board of Directors authorized a stock repurchase plan which may be used to repurchase shares of the Company's outstanding Class A common stock and warrants to purchase shares of Class A common stock. Class A common stock and warrants may be repurchased from time to time in open market transactions, in privately negotiated transactions, including with employees or otherwise, pursuant to the requirements of Rule 10b5-1 and Rule 10b-18 of the Exchange Act, as well as to retire (by cash settlement or the payment of tax withholding amounts upon net settlement) equity-based awards granted under our 2020 Incentive Award Plan, as amended and restated (and any successor plan thereto), with the terms and conditions of these repurchases depending on legal requirements, price, market and economic conditions and other factors. The Company is not obligated under the terms of the plan to repurchase any of its Class A common stock or warrants, the program has no expiration date and the Company may suspend or terminate the program at any time without prior notice. Any shares of Class A common stock and any warrants repurchased as part of this program will be canceled. GCMG's Board of Directors has made subsequent increases to its original stock repurchase authorization amount for shares and warrants. As of December 31, 2024, the total authorization was $140 million, excluding fees and expenses. On February 6, 2025, GCMG's Board of Directors increased the firm's existing repurchase authorization by $50 million, from $140 million to $190 million. On

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

August 4, 2025, GCMG's Board of Directors further increased the Company's existing repurchase authorization by $30 million, from $190 million to $220 million.

During the three and six months ended June 30, 2025, the Company repurchased 1,947,346 and 1,970,106 shares, respectively, which reflects both RSUs that were settled in cash and shares retired in connection with the net share settlement of equity-based awards, for $24.6 million and $24.9 million, or an average of $12.61 and $12.62 per share, respectively. See Note 10 for additional information regarding RSUs. Other than the deemed repurchases described above, the Company did not repurchase shares of Class A common stock during the three and six months ended June 30, 2025. As of June 30, 2025, the Company had $57.2 million remaining under the stock repurchase plan.

**7. Warrants**

The public and private warrants meet the definition of a derivative under ASC 815 and the Company records these warrants as liabilities in the Condensed Consolidated Statements of Financial Condition at fair value, with subsequent changes in their respective fair values recorded in the change in fair value of warrant liabilities within the Condensed Consolidated Statements of Income (Loss) at each reporting date.

Each public warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment. The warrants expire 5 years after the consummation of the Transaction, or earlier upon redemption or liquidation. The public warrant holders do not have the rights or privileges of holders of Class A common stock and any voting rights until they exercise their warrants and receive shares of Class A common stock. After the issuance of shares of Class A common stock, upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by stockholders.

The private placement warrants (including the Class A common stock issuable upon exercise of the private placement warrants) will not be redeemable by the Company so long as they are held by CF Sponsor, Holdings or their permitted transferees. CF Sponsor, Holdings or their permitted transferees, have the option to exercise the private placement warrants on a cashless basis.

The following table shows public and private warrants outstanding for the three months ended June 30, 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** |
| | **Public Warrants** | **Private Warrants** | **Total** | **Public Warrants** | **Private Warrants** | **Total** |
| Outstanding, beginning of period | 16544780 | 900000 | 17444780 | 16784970 | 900000 | 17684970 |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercises of warrants |  |  |  | (240190) |  | (240190) |
| Outstanding, end of period | 16544780 | 900000 | 17444780 | 16544780 | 900000 | 17444780 |

---

During the six months ended June 30, 2025, 240,190 public warrants were exercised resulting in $2.8 million of proceeds. No warrants were exercised or repurchased during the three months ended June 30, 2025 and the three and six months ended June 30, 2024. The company had 16,784,970 of public warrants and 900,000 of private warrants outstanding for each of the three and six months ended June 30, 2024.

**8. Variable Interest Entities** 

The Company consolidates VIEs when it determines that it is the primary beneficiary. Based on this assessment, the Company consolidates a certain VIE in the Condensed Consolidated Statements of Financial Condition. Creditors (or beneficial interest holders) of the VIEs do not have recourse to the Company's general credit. As of December 31, 2024, the consolidated VIE did not have any assets or liabilities.

The carrying amounts of consolidated VIE's assets and liabilities, adjusting for intercompany eliminations, were as follows:

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

---

| | |
|:---|:---|
| | **As of** |
| | **June 30, 2025** |
| **Assets** | |
| &nbsp;&nbsp;Cash and cash equivalents | $712 |
| &nbsp;&nbsp;Management fees receivable | 1023 |
| &nbsp;&nbsp;Other assets | 264 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $1999 |
| **Liabilities** |  |
| &nbsp;&nbsp;Accrued expenses and other liabilities | 1805 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $1805 |

---

The Company holds variable interests in certain entities that are VIEs which are not consolidated, as it is determined that the Company is not the primary beneficiary. The Company's involvement with such entities is generally in the form of direct equity interests in, and fee arrangements with, the entities in which it also serves as the general partner or managing member. The Company evaluated its variable interests in the VIEs and determined it is not considered the primary beneficiary of the entities primarily because it does not have interests in the entities that could potentially be significant. No reconsideration events that caused a change in the Company's consolidation conclusions occurred during either the six months ended June 30, 2025 or the year ended December 31, 2024. As of June 30, 2025 and December 31, 2024, the total unfunded commitments from the special limited partner and general partners to the unconsolidated VIEs were $74.7 million and $51.6 million, respectively. These commitments are the primary source of financing for the unconsolidated VIEs.

The following table sets forth certain information regarding the VIEs in which the Company holds a variable interest but does not consolidate. The assets recognized on the Company's Condensed Consolidated Statements of Financial Condition relate to the Company's interests in and management fees, incentive fees and third party costs receivables from these non-consolidated VIEs. The Company's maximum exposure to loss relating to non-consolidated VIEs as of June 30, 2025 and December 31, 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| | **June 30, 2025** | **December 31, 2024** |
| Investments | $114067 | $125504 |
| Receivables | 16762 | 19126 |
| Maximum exposure to loss | $130829 | $144630 |

---

The above table includes investments in VIEs which are owned by noncontrolling interest holders of approximately $24.1 million and $35.4 million as of June 30, 2025 and December 31, 2024, respectively.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**9. Employee Compensation and Benefits**

For the three and six months ended June 30, 2025 and 2024, employee compensation and benefits consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Cash-based employee compensation and benefits  | $38658 | $38733 | $77705 | $76006 |
| Equity-based compensation | 6776 | 5335 | 27077 | 30805 |
| Partnership interest-based compensation | 16323 | 11588 | 28548 | 41590 |
| Carried interest compensation | 9281 | 6860 | 14606 | 9402 |
| Cash-based incentive fee related compensation | 3832 | 5260 | 8990 | 9449 |
| Other non-cash compensation | (7) | 179 | 177 | 350 |
| Total employee compensation and benefits | $74863 | $67955 | $157103 | $167602 |

---

**Partnership Interest in Holdings, Holdings II and Management LLC**

Payments and settlements for partnership interest awards to the employees are made by GCMH Equityholders. As a result, the Company records a non-cash profits interest compensation charge and an offsetting deemed contribution to equity (deficit) to reflect the payments or settlements made or owed by the GCMH Equityholders. Since payments or settlements are made by Holdings, Holdings II and Management LLC, the expense that is pushed down to GCMH and the offsetting deemed contribution are each attributed solely to noncontrolling interests in GCMH. Any liability related to the awards is recognized at Holdings, Holdings II or Management LLC as Holdings, Holdings II or Management LLC is the party responsible for satisfying the obligation, and is not shown in the Company's Condensed Consolidated Financial Statements. The Company has recorded deemed contributions to equity (deficit) from Holdings, Holdings II and Management LLC of $16.3 million and $11.6 million for the three months ended June 30, 2025 and 2024, respectively, and $28.5 million and $41.6 million for the six months ended June 30, 2025 and 2024, respectively, for partnership interest-based compensation expense which was or will ultimately be paid or settled by Holdings, Holdings II or Management LLC.

GCMH Equityholders have modified awards to certain individuals upon their voluntary retirement or intention to retire as employees. These awards generally include a stated target amount that, upon payment, terminates the recipient's rights to future distributions and allows for a lump sum buy-out of the awards, at the discretion of the managing member of Holdings, Holdings II, and Management LLC. The awards are accounted for as partnership interest-based compensation at the fair value of these expected future payments, in the period the employees accepted the offer when there is no continued service required. The Company recognized partnership interest-based compensation expense related to award modifications of $7.3 million for the three months ended June 30, 2025, and $12.7 million and $18.5 million for the six months ended June 30, 2025 and 2024, respectively. None was recognized for the three months ended June 30, 2024.

The liability associated with awards that contain a stated target has been retained by Holdings as of June 30, 2025 and December 31, 2024 and is re-measured at each reporting date, with any corresponding changes in liability being reflected as employee compensation and benefits expense of the Company. Certain recipients had unvested stated target payments of $13.3 million as of June 30, 2025, which will be reflected as employee compensation and benefits expense by the Company over the service period. No recipients had unvested stated target payments as of June 30, 2024. The Company recognized partnership interest-based compensation expense of $7.3 million and $2.4 million for the three months ended June 30, 2025 and 2024, respectively, and $10.2 million and $4.8 million for the six months ended June 30, 2025 and 2024, respectively, related to profits interest awards that are in substance profit-sharing arrangements.

*GCMH Equityholders Awards*

In the year ended December 31, 2022, GCMH Equityholders entered into agreements that will transfer equity ownership between certain existing employee members of the GCMH Equityholders ("GCMH Equityholders Awards"). The GCMH Equityholders Awards will entitle recipients to receive Class A common stock upon vesting. The non-cash awards serve to transfer equity ownership from existing GCMH Equityholders to other existing member employees upon vesting. The GCMH

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

Equityholders Awards did not dilute Class A common stockholders and did not impact cash flows of the Company. The GCMH Equityholders Awards are accounted for under ASC 718, *Compensation—Stock Compensation*. The awards generally will vest in May 2025 and do not entitle the recipients to dividends or distributions made on Class A common stock during the vesting period. As such, the fair value of the GCMH Equityholders Awards is based on the closing price of Class A common stock on the accounting grant date less the present value of dividends expected to be paid during the vesting period. GCMH Equityholders can settle the awards at various dates after vesting by exchanging outstanding GCMH common units or by otherwise acquiring and delivering Class A common stock, and therefore the vesting of such awards will not dilute Class A common stockholders. As such, the expense that is pushed down to GCMH and the offsetting deemed contribution are each attributed solely to noncontrolling interests in GCMH, consistent with the accounting for payments to employees described above. The GCMH Equityholders Awards of 7,169,415 units had an aggregate grant date fair value of $53.4 million, or an average grant date fair value of $7.45 per unit. See Note 10 for additional information on a modified GCMH Equityholder Award during the six months ended June 30, 2025. The Company recognized partnership interest-based compensation expense related to the GCMH Equityholders Awards of $1.7 million and $5.5 million for the three months ended June 30, 2025 and 2024, respectively, and $5.6 million and $10.9 million for the six months ended June 30, 2025 and 2024, respectively. As of June 30, 2025, all compensation expense related to GCMH Equityholders Awards has been recognized.

*Holdings Awards*

On May 9, 2023, Holdings entered into amended and restated participation certificates with existing employee members ("Holdings Awards"). The Holdings Awards entitle recipients to a stated percentage, or minimum allocable share, of distributions from Holdings, as well as a profits interest with respect to net sale proceeds from dispositions of Holdings properties after certain threshold distributions to other members. Pursuant to ASC 505, the Holdings Awards will be recognized as compensation expense with a corresponding deemed contribution and are accounted for under ASC 718, *Compensation—Stock Compensation* as the awards have characteristics that are more akin to the risks and rewards of equity ownership in Holdings. These awards do not dilute Class A common stockholders or impact net cash flows of the Company.

Certain of these existing employee members were previously awarded target amounts that entitled them to a stated percentage, or minimum allocable share, of distributions from Holdings until they received a sum certain. Those target amounts represented by those sums, which were previously recorded as partnership interest-based compensation, were reduced to zero in the amended and restated participation certificates. As a result, target amounts that were previously recorded as partnership interest-based compensation were reversed, while partnership interest-based compensation associated with the amended and restated participation certificates is recorded.

The Holdings Awards had an aggregate grant date fair value of $155.5 million, which was partially offset when recognized in expense by $80.0 million target amounts reversed during the year ended December 31, 2023. The fair value of the Holdings Awards was determined by a third-party valuation firm utilizing a discounted cash flow analysis for the minimum allocable share and a Monte Carlo simulation valuation model for the profits interest with respect to net sale proceeds from dispositions of Holdings properties after the threshold distributions. Significant valuation inputs and assumptions included Holdings projected financial information and distributions, an estimated 10 year holding period, a 15.4% cost of equity, a 13.0% weighted average cost of capital, a 35% volatility assumption, the likelihood of a defined conversion event, a 40% discount for lack of marketability, and the fair value of reference properties that determine the threshold distributions for the profits interest with respect to net sale proceeds. The resulting fair value of the Holdings Awards is pushed down from Holdings to the Company and recorded as compensation expense. A portion of the Holdings Awards were vested upon grant, resulting in immediate expense recognition. The Company recognized partnership interest-based compensation expense related to the Holdings Awards of $3.7 million and $7.4 million for the three and six months ended June 30, 2024, respectively. The Company did not recognize any partnership interest-based compensation expense related to the Holdings Awards for each of the three and six months ended June 30, 2025 as all compensation expense related to the Holdings Awards was previously recognized.

**Other**

Other consists of employee compensation and benefits expense related to deferred compensation programs and other awards that represent investments made in GCM Funds on behalf of the employees.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**10. Equity-Based Compensation** 

During the six months ended June 30, 2025, the Company granted 2.6 million equity-classified RSUs and 0.8 million liability-classified RSUs with aggregate grant date fair values of $35.2 million and $10.3 million, respectively, to certain employees. The liability-classified RSUs are either classified as liabilities because they are required to be settled in cash or because the Company has the right to and intends to (as of the grant date or June 30, 2025, as applicable) settle the RSUs partially or wholly in cash. During the six months ended June 30, 2025, the Company reclassified 1.6 million RSUs from liability-classified to equity-classified based on management's intent to settle the awards in shares of Class A common stock.

The majority of liability-classified awards outstanding as of December 31, 2024 were granted in October 2024, vested on March 1, 2025 and were delivered on April 15, 2025. Other awards generally vest either (a) one-third at the grant date with the remainder over two years in equal annual installments or (b) over a one to three year period. Upon delivery, the Company may withhold the number of shares to satisfy the statutory withholding tax obligation and deliver the net number of resulting shares vested.

See Note 9 for additional information regarding GCMH Equityholders Awards and Holdings Awards.

A summary of non-vested equity-classified RSU activity for the six months ended June 30, 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | **Number of RSUs** | **Weighted-Average Grant-Date Fair Value Per RSU** |
| Balance as of December 31, 2024 | 3251068 | $8.40 |
| &nbsp;&nbsp;&nbsp;Granted | 2583103 | 13.62 |
| &nbsp;&nbsp;&nbsp;Reclassified from liability-classified RSUs | 1627041 | 11.54 |
| &nbsp;&nbsp;&nbsp;Vested | (2987612) | 10.03 |
| &nbsp;&nbsp;&nbsp;Forfeited | (135819) | 10.27 |
| Balance as of June 30, 2025 | 4337781 | 11.50 |

---

A summary of non-vested liability-classified RSU activity for the six months ended June 30, 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | **Number of RSUs** | **Weighted-Average Grant-Date Fair Value Per RSU** |
| Balance as of December 31, 2024 | 1813249 | $10.50 |
| &nbsp;&nbsp;&nbsp;Granted | 786142 | 13.15 |
| &nbsp;&nbsp;&nbsp;Reclassified to equity-classified RSUs | (1627041) | 11.54 |
| &nbsp;&nbsp;&nbsp;Vested | (746691) | 11.66 |
| &nbsp;&nbsp;&nbsp;Forfeited | (1742) | 12.92 |
| Balance as of June 30, 2025 | 223917 | $8.40 |

---

The total grant-date fair value of RSUs that vested during the three and six months ended June 30, 2025 was $21.8 million and $38.7 million, respectively. For the three months ended June 30, 2025 and 2024, $6.8 million and $5.3 million, respectively, of compensation expense related to RSUs was recorded within employee compensation and benefits in the Condensed Consolidated Statements of Income (Loss). For the six months ended June 30, 2025 and 2024, $27.1 million and $30.8 million, respectively, of compensation expense related to RSUs was recorded within employee compensation and benefits in the Condensed Consolidated Statements of Income (Loss). As of June 30, 2025, total unrecognized compensation expense related to unvested RSUs was $45.1 million and is expected to be recognized over the remaining weighted average period of 2.7 years.

During the six months ended June 30, 2025, a modification of a GCMH Equityholder Award was made that changed settlement of 200,000 shares to be from the Company's 2020 Incentive Award Plan. Such amount is reflected as granted and vested within the equity-classified RSU activity in the rollforward above.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

The tax benefit related to RSUs that vested and were delivered during the six months ended June 30, 2025 was $2.9 million.

**11. Debt**

The table below summarizes the outstanding debt balance as of June 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| | **June 30, 2025** | **December 31, 2024** |
| Senior loan | $433620 | $435810 |
| Less: debt issuance costs | (3385) | (3771) |
| Total debt | $430235 | $432039 |

---

Maturities of debt for the next five years and thereafter as of June 30, 2025 are as follows:

---

| | |
|:---|:---|
| Remainder of 2025 | $2190 |
| 2026 | 4380 |
| 2027 | 4380 |
| 2028 | 4380 |
| 2029 | 4380 |
| Thereafter | 413910 |
| Total | $433620 |

---

**Senior Loan** 

On January 2, 2014, the Company entered into a senior secured term loan facility ("Senior Loan"), which was subsequently amended through several debt modifications.

In 2021, the Company amended its Senior Loan to extend the maturity date to February 24, 2028 and increased the aggregate principal amount thereunder to $400.0 million ("2028 Term Loans").

On June 29, 2023, the Company entered into Amendment No. 7 to the Credit Agreement to incorporate changes for the contemplated transition to the Term Secured Overnight Financing Rate ("Term SOFR"), and on July 1, 2023, in conjunction with a Benchmark Transition Event, the interest rate margin and floor defaulted to the Term SOFR plus a Benchmark Replacement Adjustment of 0.11% as recommended by the Relevant Governmental Body (all terms as defined in the Amended Credit Agreement).

On May 21, 2024, the Company entered into Amendment No. 8 to the Credit Agreement to, among other things, increase and extend the maturity of the 2028 Term Loans. The amendment increased the aggregate principal amount from $388.0 million to $438.0 million, extended the maturity date from February 24, 2028 to February 25, 2030 (as increased and extended, the "2030 Term Loans"), decreased the interest rate margin to 2.25% over Term SOFR, and removed the Benchmark Replacement Adjustment of 0.11%. The 2030 Term Loans continue to be subject to a 0.50% SOFR floor. As a result of the amendment and extension, the Company capitalized $0.4 million of debt issuances costs related to payments to lenders, which is recorded within debt in the Condensed Consolidated Statements of Financial Condition, and expensed $3.0 million of third-party costs which is recorded within general, administrative and other in the Condensed Consolidated Statements of Income (Loss) for the year ended December 31, 2024. In addition, the Company recorded an expense of $0.2 million related to the partial extinguishment of certain lenders, which is recorded within other income (expense) in the Condensed Consolidated Statements of Income (Loss) for the year ended December 31, 2024.

From June 30, 2021 until May 21, 2024 quarterly principal payments of $1.0 million were required to be made toward the 2028 Term Loans (less any reduction for prior or future voluntary or mandatory prepayments of principal). As part of

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

Amendment No. 8 to the Credit Agreement, quarterly principal payments of $1.1 million are required to be made toward the 2030 Term Loans beginning July 1, 2024 (less any reduction for prior or future voluntary or mandatory prepayments of principal).

In addition to the scheduled principal repayments, the Company is required to offer to make prepayments of Consolidated Excess Cash Flow ("Cash Flow Payments") no later than five days following the date the quarterly financial statements are due if the leverage ratio exceeds certain thresholds in the Amended Credit Agreement No. 8. The Cash Flow Payments were calculated as defined in the Senior Loan agreement based on a percentage of calculated excess cash. During the three and six months ended June 30, 2025, the Company was not required to offer to make any Cash Flow Payments.

As of June 30, 2025 and December 31, 2024, $433.6 million and $435.8 million of 2028 Term Loans were outstanding, respectively, with weighted average interest rates of 6.58% and 7.86% for the six months ended June 30, 2025 and 2024, respectively.

Under the credit and guaranty agreement governing the terms of the Senior Loan, the Company must maintain certain leverage and interest coverage ratios. The credit and guaranty agreement also contains other covenants that, among other things, restrict the ability of the Company and its subsidiaries to incur debt and restrict the Company and its subsidiaries ability to merge or consolidate, or sell or convey all or substantially all of the Company's assets. As of June 30, 2025, the Company was in compliance with all covenants.

GCMH Equityholders and IntermediateCo have executed a pledge agreement ("Pledge Agreement") and security agreement ("Security Agreement") with the lenders of the Senior Loan. Under the Pledge Agreement, GCMH Equityholders and IntermediateCo have agreed to secure the obligations under the Senior Loan by pledging its interests in GCMH as collateral against the repayment of the senior secured notes, and GCMH has agreed to secure the obligations under the Senior Loan by granting a security interest in and continuing lien on the collateral described in the Security Agreement. The Pledge Agreement and Security Agreement will remain in effect until such time as all obligations relating to the Senior Loan have been fulfilled.

**Credit Facility**

Concurrent with the issuance of the Senior Loan, the Company entered into a $50.0 million revolving credit facility ("Credit Facility"). The Credit Facility maturity date was extended from February 24, 2026 to February 24, 2028 as part of Amendment No. 8 to the Credit Agreement, and carries an unused commitment fee of up to 0.50% per annum. There were no outstanding borrowings related to the Credit Facility as of each of June 30, 2025 and December 31, 2024.

**Other**

Certain subsidiaries of the Company agree to jointly and severally guarantee, as primary obligors and not merely as surety guarantees the obligations of their parent entity, GCMH.

Amortization of deferred debt issuance costs was $0.2 million for each of the three months ended June 30, 2025 and 2024, and $0.4 million and $0.5 million for the six months ended June 30, 2025 and 2024, respectively. These amounts are recorded within interest expense in the Condensed Consolidated Statements of Income (Loss).

The carrying value of the Senior Loan, excluding the unamortized debt issuance costs presented as a reduction to the principal balance, approximated its fair value as of June 30, 2025 and December 31, 2024. As the Senior Loan was not accounted for at fair value, it was not included in the Company's fair value hierarchy in Note 5, however had it been included, it would have been classified in Level 2.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**12. Interest Rate Derivatives** 

The Company has entered into various derivative agreements with financial institutions to hedge interest rate risk related to its outstanding debt. The Company had the following interest rate derivatives recorded within accrued expenses and other liabilities as of June 30, 2025 and December 31, 2024 in the Condensed Consolidated Statements of Financial Condition:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Derivative** | **Notional Amount** | **Fair Value as of June 30, 2025** | **Fair Value as of December 31, 2024** | **Fixed Rate Paid** | **Floating Rate Received** | **Effective Date**<sup>(2)</sup> | **Maturity Date** |
| Interest rate swap | $300000 | $(6521) | $(2291) | 4.37% | 1 month Term SOFR<sup>(1)</sup> | November 2022 | February 2028 |
| Interest rate swap | $28500 | $(772) | $(397) | 4.47% | 1 month Term SOFR<sup>(1)</sup> | May 2024 | February 2028 |
| Interest rate swap | $317000 | $(4157) | $(844) | 4.17% | 1 month Term SOFR<sup>(1)</sup> | February 2028 | February 2030 |

---

____________

(1)Floating rate received subject to a 0.50% floor.

(2)Represents the date at which the derivative is in effect and the Company is contractually required to begin payment of interest under the terms of the agreement.

A rollforward of the amounts in accumulated other comprehensive income (loss) ("AOCI") related to interest rate derivatives designated as cash flow hedges is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Derivative gain at beginning of period | $11632 | $25007 | $18342 | $21806 |
| &nbsp;&nbsp;Amount recognized in other comprehensive income (loss)<sup>(1)</sup> | (2240) | 141 | (7037) | 6042 |
| &nbsp;&nbsp;Amount reclassified from accumulated other comprehensive income (loss) to interest expense | (1929) | (2726) | (3842) | (5426) |
| Derivative gain at end of period | 7463 | 22422 | 7463 | 22422 |
| &nbsp;&nbsp;Less: gain attributable to noncontrolling interests in GCMH | 6644 | 18810 | 6644 | 18810 |
| Derivative gain at end of period, net | $819 | $3612 | $819 | $3612 |

---

____________

(1)Net tax provision (benefit) of $(0.4) million and $(0.8) million for the three and six months ended June 30, 2025, respectively, and $(0.3) million and less than $0.1 million for the three and six months ended June 30, 2024, respectively.

In October 2022, the Company terminated two derivative instruments with effective dates that started in 2021, and maturity dates in 2028. The Company received $40.3 million of cash for the fair market value of the interest rate swaps at termination in October 2022. The amounts previously recorded as hedges in AOCI will remain in AOCI and will be recorded in interest expense within the Condensed Consolidated Statements of Comprehensive Income (Loss) over the original lives of the derivative instruments.

The Company reclassified $1.9 million for each of the three months ended June 30, 2025 and 2024, and $3.8 million for each of the six months ended June 30, 2025 and 2024, from AOCI to interest expense, relating to the derivative instruments terminated that initially qualified for hedge accounting. The net impact of these reclassifications decreased interest expense for each of the three and six months ended June 30, 2025 and 2024.

Effective on November 1, 2022, the Company entered into a swap agreement to hedge interest rate risk related to payments made for the 2028 Term Loans that has a notional amount of $300 million and a fixed rate of 4.37%. The swap agreement and the 2028 Term Loans had a 0.50% LIBOR floor through June 30, 2023 and defaulted to Term SOFR plus a Benchmark Replacement Adjustment on July 1, 2023 at the Benchmark Transition Event as discussed in Note 11. The swap

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

was determined to be an effective cash flow hedge at inception based on a comparison of critical terms and remained an effective cash flow hedge at and following the Benchmark Transition Event.

Effective on May 31, 2024, the Company entered into a swap agreement to hedge interest rate risk related to payments made for the increase in aggregate principal amount of the 2030 Term Loans that has a notional amount of $28.5 million and a fixed rate of 4.47%. The swap agreement and 2030 Term Loans have a 0.50% Term SOFR floor. The swap was determined to be an effective cash flow hedge at inception based on a comparison of critical terms.

On May 23, 2024, the Company entered into a forward-starting swap agreement to hedge interest rate risk related to payments made during the extended maturity of the 2030 Term Loans that has an effective date of February 2028, a notional amount of $317.0 million, and a fixed rate of 4.17%. The forward-starting swap agreement and 2030 Term Loans have a 0.50% Term SOFR floor. The swap was determined to be an effective cash flow hedge at inception based on a comparison of critical terms.

The fair values of the interest rate swaps are based on observable market inputs and represent the net amount required to terminate the positions, taking into consideration market rates and non-performance risk. Refer to Note 5 for additional information.

During the next twelve months, the Company expects to reclassify approximately $6.1 million from AOCI to interest expense, which will decrease interest expense, including the impact of the swap terminations.

**13. Commitments and Contingencies** 

**Leases**

The Company has entered into operating lease agreements for office space. The Company leases office space in various countries around the world and maintains its headquarters in Chicago, Illinois, where it leases primary office space. The leases contain rent escalation clauses based on increases in base rent, real estate taxes and operating expenses. Some leases offer the option to extend for an additional term or terminate early. The Company generally does not include options to renew when determining the lease term as it is not reasonably certain at contract inception that the Company will exercise the option(s). As the implicit rate is not generally readily determinable, the Company uses its incremental borrowing rate to determine the present value of future minimum lease payments. The Company's leases have remaining lease terms of less than one year to 14 years.

The components of operating lease expense recorded within general, administrative and other in the Condensed Consolidated Statements of Income (Loss) were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Operating lease cost<sup>(1)</sup> | $1879 | $3069 | $3752 | $5948 |
| Variable lease cost<sup>(2)</sup> | 1171 | 982 | 2200 | 2077 |
| Less: sublease income | 53 | 49 | 104 | 115 |
| Total lease cost | $2997 | $4002 | $5848 | $7910 |

---

____________

(1)Includes $0.1 million of short term lease expense for the each of the three and six months ended June 30, 2025 and 2024. For the three and six months ended June 30, 2024, includes lease cost for two offices in New York due to the build out of new office space.

(2)Includes common area maintenance charges and other variable costs not included in the measurement of ROU assets and lease liabilities.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

The following table summarizes cash flows and other supplemental information related to our operating leases:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** |
| Cash paid for amounts included in the measurement of operating lease liabilities | $4110 | $3051 |
| Non-cash ROU assets obtained in exchange for new and extended operating leases | $1967 | $8953 |
| Weighted average remaining lease term in years | 13.1 years | 13.7 years |
| Weighted average discount rate | 6.3% | 6.4% |

---

As of June 30, 2025, the maturities of operating lease liabilities were as follows:

---

| | |
|:---|:---|
| Remainder of 2025 | $4208 |
| 2026 | 5889 |
| 2027 | 7148 |
| 2028 | 7219 |
| 2029 | 5971 |
| Thereafter | 61457 |
| Total lease payments | 91892 |
| &nbsp;&nbsp;&nbsp;Less: tenant improvement allowance | (8706) |
| &nbsp;&nbsp;&nbsp;Less: imputed interest | (29617) |
| Total operating lease liabilities | $53569 |

---

**Commitments**

The Company owns a 6.25% interest in an aircraft and is required to pay a fixed management fee of $0.3 million per year until September 3, 2029.

The Company had $126.6 million and $90.5 million of unfunded investment commitments as of June 30, 2025 and December 31, 2024, respectively, representing general partner capital funding commitments to several of the GCM Funds and other commitments to our equity method investments.

**Litigation**

In the normal course of business, the Company may enter into contracts that contain a number of representations and warranties, which may provide for general or specific indemnifications. The Company's exposure under these contracts is not currently known, as any such exposure would be based on future claims, which could be made against the Company. The Company's management is not currently aware of any such pending claims and based on its experience, the Company believes the risk of loss related to these arrangements to be remote.

From time to time, the Company is a defendant in various lawsuits related to its business. The Company's management does not believe that the outcome of any current litigation will have a material effect on the Company's Condensed Consolidated Financial Statements.

**Off-Balance Sheet Risks**

The Company may be exposed to a risk of loss by virtue of certain subsidiaries serving as the general partner of GCM Funds organized as limited partnerships. As general partner of a GCM Fund organized as a limited partnership, the Company's subsidiaries that serve as the general partner have exposure to risk of loss that is not limited to the amount of its investment in such GCM Fund. The Company cannot predict the amount of loss, if any, which may occur as a result of this exposure; however, historically, the Company has not incurred any significant losses and management believes the likelihood is remote that a material loss will occur.

------

**GCM Grosvenor Inc.**

**Notes to Consolidated Financial Statements**

***(In thousands, except share amounts and where otherwise noted)***

**14. Related Parties**

In regard to the following related party disclosures, the Company's management cannot be sure that such transactions or arrangements would be the same to the Company if the parties involved were unrelated and such differences could be material.

The Company provides certain employees partnership interest awards which are paid or settled by Holdings, Holdings II and Management LLC. Refer to Note 9 for further details.

The Company has a sublease agreement with Holdings. Because the terms of the sublease are identical to the terms of the original and extension leases, there is no impact to net income (loss) in the Condensed Consolidated Statements of Income (Loss) or Condensed Consolidated Statements of Cash Flows.

The Company incurs certain costs, primarily related to accounting, client reporting, investment-decision making and treasury-related expenditures, for which it receives reimbursement from the GCM Funds in connection with its performance obligations to provide investment management services. The Company also incurs certain costs, primarily related to employee benefits and travel, for which it receives reimbursement from Holdings. Due from related parties in the Condensed Consolidated Statements of Financial Condition includes net receivables from GCM Funds of $11.2 million and $12.6 million and from Holdings of less than $0.1 million as of June 30, 2025 and December 31, 2024, respectively, paid on behalf of affiliated entities that are reimbursable to the Company.

Our executive officers, senior professionals, and certain current and former employees and their families invest on a discretionary basis in GCM Funds, and such investments are generally not subject to management fees and performance fees.

Certain employees of the Company have an economic interest in an entity that is the owner and landlord of the building in which the principal headquarters of the Company are located. The Company paid $0.7 million and $1.3 million for the three and six months ended June 30, 2025, respectively, and $0.6 million and $1.3 million for the three and six months ended June 30, 2024, respectively, related to this lease. This expense is recorded within general, administrative and other in the Condensed Consolidated Statements of Income (Loss).

The Company utilizes the services of an insurance broker to procure insurance coverage, including its general commercial package policy, workers' compensation and professional and management liability coverage for its directors and officers. Certain members of Holdings have an economic interest in, and relatives are employed by, the Company's insurance broker.

From time to time, certain of the Company's executive officers utilize a private business aircraft, including an aircraft wholly owned or controlled by members of Holdings. Additionally, the Company arranges for the use of the private business aircraft through a number of charter services, including entities predominantly or wholly owned or controlled by members of Holdings. The Company paid, net of reimbursements, $0.7 million and $1.5 million for the three and six months ended June 30, 2025, respectively, and $0.8 million for each of the three and six months ended June 30, 2024, to utilize aircraft and charter services wholly owned or controlled by members of Holdings, which is recorded within general, administrative and other in the Condensed Consolidated Statements of Income (Loss).

In an internal restructuring effective January 1, 2024, GCMH acquired from its general partner, IntermediateCo, the equity interests in GCM, L.L.C. held by IntermediateCo for cash consideration in the amount of approximately $2.0 million. The transaction was completed in accordance with the terms of a transfer agreement. IntermediateCo, a wholly owned subsidiary of GCM Grosvenor Inc., acquired GCM, L.L.C. in connection with the Transaction for nominal consideration and continues to control GCM, L.L.C. indirectly as general partner of GCMH.

**15. Income Taxes** 

The Company's effective tax rate used for interim periods is based on the tax effect of items recorded discretely in the interim period in which those items occur. The effective tax rate is dependent on many factors, including the estimated amount of income subject to income tax and allocation of tax benefit to noncontrolling interest; therefore, the effective tax rate can vary from period to period. The Company evaluates the realizability of its deferred tax asset on a quarterly basis and adjusts the valuation allowance when it is expected a portion of the deferred tax asset may not be realized.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

The Company's effective tax rate was (1)% and 20% for the three months ended June 30, 2025 and 2024, respectively, and 8% and (273)% for the six months ended June 30, 2025 and 2024, respectively. These rates were different than the statutory rate primarily due to the portion of income allocated to the noncontrolling interest holders, including profits interest expense, as well as a valuation allowance recorded against deferred tax assets and discrete tax adjustments recorded in the periods.

As of June 30, 2025, the Company had $1.1 million in unrecognized tax positions and believes there will be no material changes to the uncertain tax benefits related to its uncertain tax positions within the next 12 months.

On July 4, 2025, H.R.1 (known commonly as the One Big Beautiful Bill Act ("OBBBA")) was enacted into law. The OBBBA included several tax provisions, including extensions of certain provisions of the Tax Cuts and Jobs Act of 2017. Since the OBBBA was passed after June 30, 2025, there is no impact on our financial statements for the three and six months ended June 30, 2025. The Company is in the process of evaluating the financial statement impact of these provisions effective in future periods.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**16. Earnings (Loss) Per Share**

The following is a reconciliation of basic and diluted earnings (loss) per share for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Numerator for earnings (loss) per share calculation:** |  |  |  |  |
| &nbsp;&nbsp;Net income attributable to GCM Grosvenor Inc., basic | $15437 | $4800 | $15900 | $6924 |
| &nbsp;&nbsp;Exchange of Partnership units | (994) | 3418 | 977 | (22234) |
| &nbsp;&nbsp;Exercise of private warrants | (297) |  | (166) |  |
| &nbsp;&nbsp;Exercise of public warrants | (4592) |  | (2473) |  |
| &nbsp;&nbsp;Net income (loss) attributable to common stockholders, diluted | $9554 | $8218 | $14238 | $(15310) |
| **Denominator for earnings (loss) per share calculation:** |  |  |  |  |
| &nbsp;&nbsp;Weighted-average shares, basic | 51074156 | 44934623 | 48367585 | 44302442 |
| &nbsp;&nbsp;Exchange of Partnership units | 142823480 | 144235246 | 143525463 | 144235246 |
| &nbsp;&nbsp;Exercise of private warrants - incremental shares under the treasury stock method | 63298 |  | 94589 |  |
| &nbsp;&nbsp;Exercise of public warrants - incremental shares under the treasury stock method | 1163618 |  | 1749494 |  |
| &nbsp;&nbsp;Assumed vesting of RSUs - incremental shares under the treasury stock method | 1214043 | 1008404 | 1904029 |  |
| &nbsp;&nbsp;Weighted-average shares, diluted | 196338595 | 190178273 | 195641160 | 188537688 |
| **Basic EPS** |  |  |  |  |
| &nbsp;&nbsp;Net income attributable to common stockholders, basic | $15437 | $4800 | $15900 | $6924 |
| &nbsp;&nbsp;Weighted-average shares, basic | 51074156 | 44934623 | 48367585 | 44302442 |
| &nbsp;&nbsp;Net income per share attributable to common stockholders, basic | $0.30 | $0.11 | $0.33 | $0.16 |
| **Diluted EPS** |  |  |  |  |
| &nbsp;&nbsp;Net income (loss) attributable to common stockholders, diluted | $9554 | $8218 | $14238 | $(15310) |
| &nbsp;&nbsp;Weighted-average shares, diluted | 196338595 | 190178273 | 195641160 | 188537688 |
| &nbsp;&nbsp;Net income (loss) per share attributable to common stockholders, diluted | $0.05 | $0.04 | $0.07 | $(0.08) |

---

When applying the if-converted method to calculate the potential dilutive impact of the exchangeable common units of the Partnership, the earnings (loss) per share numerator adjustment reflects the net income (loss) attributable to noncontrolling interests in GCMH, as reported, adjusted for the hypothetical incremental provision for income taxes that would have been recorded by the Company if the units had been converted.

Shares of the Company's Class C common stock do not participate in the earnings or losses of the Company and are therefore not participating securities. As such, a separate presentation of basic and diluted earnings (loss) per share of Class C common stock under the two-class method has not been presented.

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

The following outstanding potentially dilutive securities were excluded from the calculations of diluted earnings (loss) per share attributable to common stockholders because their impact would have been antidilutive for the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Public warrants |  | 16784970 |  | 16784970 |
| Private warrants |  | 900000 |  | 900000 |
| Unvested RSUs under the treasury stock method |  |  |  | 1639536 |

---

------

**GCM Grosvenor Inc.**

**Notes to Condensed Consolidated Financial Statements** 

**(Unaudited)**

***(In thousands, except share and per share amounts and where otherwise noted)***

**17. Segments**

For the three and six months ended June 30, 2025, there have been no changes in the basis of segmentation or in the basis of measurement of assessing segment performance for the Company's single reportable segment.

The following table presents the Company's segment operating revenue, significant segment expenses, other income, and segment net income (loss) for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Segment operating revenue | $119657 | $116954 | $245503 | $225820 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;Cash-based employee compensation and benefits | 38658 | 38733 | 77705 | 76006 |
| &nbsp;&nbsp;Equity-based compensation | 6776 | 5335 | 27077 | 30805 |
| &nbsp;&nbsp;Partnership interest-based compensation | 16323 | 11588 | 28548 | 41590 |
| &nbsp;&nbsp;Carried interest compensation | 9281 | 6860 | 14606 | 9402 |
| &nbsp;&nbsp;Cash-based incentive fee related compensation | 3832 | 5260 | 8990 | 9449 |
| &nbsp;&nbsp;Other non-cash compensation | (7) | 179 | 177 | 350 |
| &nbsp;&nbsp;General, administrative and other<sup>(1)</sup> | 25549 | 28164 | 53825 | 53343 |
| &nbsp;&nbsp;Investment income | (5782) | (1290) | (6546) | (6967) |
| &nbsp;&nbsp;Interest expense | 5908 | 6134 | 11571 | 12057 |
| &nbsp;&nbsp;Other income<sup>(2)</sup> | (1182) | (394) | (2028) | (947) |
| &nbsp;&nbsp;Change in fair value of warrants | (19388) | 180 | (10612) | 2324 |
| &nbsp;&nbsp;Provision (benefit) for income taxes | (202) | 3244 | 3389 | 4354 |
| Segment net income (loss) | $39891 | $12961 | $38801 | $(5946) |
| *Reconciliation of profit or loss* |  |  |  |  |
| Adjustments and reconciling items |  |  |  |  |
| Consolidated net income (loss) | $39891 | $12961 | $38801 | $(5946) |

---

____________

(1)General, administrative and other consists primarily of professional fees, travel and related expenses, IT operations, communications and information services, occupancy, fund expenses, depreciation and amortization, and other costs associated with our operations.

(2)Other income consists primarily of other non-operating items, including interest income.

**18. Subsequent Events** 

On August 4, 2025, GCMG's Board of Directors declared a quarterly dividend of $0.11 per share of Class A common stock to record holders as of the close of business on September 2, 2025. The payment date will be September 16, 2025.

------

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*You should read the following discussion and analysis of our financial condition and results of operations together with the Annual Report on Form 10-K for the fiscal year ended December 31, 2024. This discussion contains forward-looking statements that reflect our plans, estimates, and beliefs that involve risks and uncertainties. As a result of many factors, such as those set forth under the "Risk Factors" section of Part I, Item IA in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and under the "Forward-Looking Statements" section elsewhere in this Quarterly Report on Form 10-Q, our actual results may differ materially from those anticipated in these forward-looking statements.* 

**Overview**

We are a leading alternative asset management solutions provider that invests across all major alternative investment strategies. We invest on a primary basis and through direct-oriented strategies, which we define as secondaries, co-investments, direct investments and seed investments. We operate customized separate accounts and commingled funds. We collaborate with our clients to invest on their behalf across the private and public markets, either through portfolios customized to meet a client's specific objectives or through specialized commingled funds that are developed to meet broad market demands for strategies and risk-return objectives.

We operate at scale across the full range of private markets and absolute return strategies. Private markets and absolute return strategies are primarily defined by the liquidity of the underlying securities purchased, the length of the client commitment, and the form and timing of incentive fees. For private markets strategies, clients generally commit to invest over a three-year time period and have an expected duration of seven years or more. In private markets strategies, carried interest is typically based on realized gains on liquidation of the investment. For absolute return strategies, the securities tend to be more liquid, clients have the ability to redeem assets more regularly, and performance fees can be earned on an annual basis. We offer the following investment strategies:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Private Equity

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Infrastructure

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Real Estate

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Absolute Return Strategies

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Alternative Credit

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sustainable and Impact Investing

Our clients include large, sophisticated, global institutional investors who rely on our investment expertise and differentiated investment access to navigate the alternatives market, but also include a growing individual investor client base. As one of the pioneers of the customized separate account solutions, we are equipped to provide investment services to clients with a wide variety of needs, internal resources and investment objectives, and our client relationships are deep and frequently span decades.

**Trends Affecting Our Business**

As a global alternative asset manager, our results of operations are impacted by a variety of factors, including conditions in the global financial markets and economic and political environments, particularly in the United States, Europe, Asia-Pacific, Latin America and the Middle East. While economic factors, such as interest rates, can make alternative investments more or less attractive relative to other asset classes, investors have increasingly gravitated towards the returns generated by alternative investments in order to meet their return objectives. In addition, increased equity market volatility can also contribute to increased investor demand for alternative strategies. We have observed such volatility in the first half of 2025 in the United States, driven by elevated inflation, economic slowdown and potential implications of U.S. trade tariffs. Finally, the opportunities in private markets continue to expand as firms raise new funds and launch new vehicles and products to access private markets across the globe.

------

In addition to the trends discussed above, we believe the following factors, among others, will influence our future performance and results of operations:

***Our ability to retain existing investors and attract new investors in our funds.***

Our ability to retain existing assets under management and attract new investors in our funds is partially dependent on the extent to which investors continue to favorably see the alternative asset management industry relative to traditional publicly listed equity and debt securities. A decline in the pace or the size of our fundraising efforts or investments as a result of increased competition in the private markets investing environment or a shift toward public markets may impact our revenues, which are generated from management fees and incentive fees.

***Our ability to expand our business through new lines of business and geographic markets.***

Our ability to grow our revenue base is partially dependent upon our ability to offer additional products and services by entering into new lines of business and by entering into, or expanding our presence in, new geographic markets. Entry into certain lines of business or geographic markets or the introduction of new types of products or services may subject us to the evolving macroeconomic and regulatory environment of the various countries where we operate or in which we invest.

***Our ability to realize investments.***

Challenging market and economic conditions may adversely affect our ability to exit and realize value from our investments and we may not be able to find suitable investments in which to effectively deploy capital. During periods of adverse economic conditions, such as current geopolitical turmoil abroad and elevated inflation and interest rates, our funds may have difficulty accessing financial markets, which could make it more difficult to obtain funding for additional investments and impact our ability to successfully exit positions in a timely manner. A general market downturn, a recession or a specific market dislocation may result in lower investment returns for our funds, which would adversely affect our revenues.

***Our ability to identify suitable investment opportunities for our clients.***

Our success largely depends on the identification and availability of suitable investment opportunities for our clients, including the success of the investment vehicles managed by third-party investment managers in which GCM Funds invest. The availability of investment opportunities is subject to certain factors outside of our control, including the market environment at a given point in time. Although there can be no assurance that we will be able to secure the opportunity to invest on behalf of our clients in all or a substantial portion of the investments we select, or that the size of the investment opportunities available to us will be as large as we would desire, we seek to maintain excellent relationships with investment managers that we have invested with previously or who we may invest with in the future. These investment managers include investment managers of investment funds as well as sponsors of investments that might provide co-investment opportunities in portfolio companies alongside the fund manager. Our ability to identify attractive investments and execute those investments is dependent on a number of factors, including the general macroeconomic environment, valuation, transaction size, and expected duration of such investment opportunity.

***Our ability to generate competitive returns.***

The ability to attract and retain clients is partially dependent on returns we are able to deliver versus client objectives, our peers and industry benchmarks. The capital we are able to attract drives the growth of our assets under management and the management and incentive fees we earn. Similarly, in order to maintain our desired fee structure in a competitive environment, we must be able to continue to provide clients with investment returns and service that incentivize our investors to pay our desired fee rates.

***Our ability to comply with increasing and evolving regulatory requirements.***

The complex and evolving regulatory and tax environment may have an adverse effect on our business and subject us to additional expenses or capital requirements, as well as restrictions on our business operations.

For example, on July 4, 2025, H.R. 1, the "One Big Beautiful Bill Act" (the "OBBBA") was signed into law in the United States. Among other changes, the OBBBA modifies key business tax provisions, including the restoration of 100% bonus depreciation under Section 168(k) of the United States Internal Revenue Code of 1986, as amended (the "Internal Revenue Code"), the restoration of the immediate deduction of U.S. domestic research and experimental expenditures under Section 174A of the Internal Revenue Code, the restoration of the EBITDA-based business interest expense limitation under

------

Section 163(j) of the Internal Revenue Code, and changes to the computation of taxes related to international operations. As the OBBBA was passed after June 30, 2025, there is no impact on our financial statements for the three and six months ended June 30, 2025, but we are currently evaluating the impact that OBBBA may have on our future financial condition and results of operations. Regulations and other United States Internal Revenue Service guidance implementing the OBBBA may give rise to new issues that we did not foresee, and further changes to tax laws may be implemented.

**Operating Segments**

We have determined that we operate in a single operating and reportable segment. This is consistent with how our chief operating decision maker, who is our Chief Executive Officer, allocates resources and assesses performance.

**Organizational Structure** 

The diagram below depicts our current organizational structure:

![Org Chart Q2'25.jpg](gcm-20250630_g1.jpg)

Note: The diagram depicts a simplified version of our structure and does not include all legal entities in our structure. Approximate ownership percentages are as of August 4, 2025.

(1)Mr. Sacks, the chairman of our board of directors and our Chief Executive Officer, ultimately owns and controls GCM V. The address for Mr. Sacks is c/o GCM Grosvenor, 900 North Michigan Avenue, Suite 1100, Chicago, Illinois 60611.

(2)Percentage of combined voting power represents voting power with respect to all shares of Class A common stock and Class C common stock, voting together as a single class. Each holder of Class A common stock is entitled to one vote per share, and each holder of Class C common stock is entitled to the lesser of (i) 10 votes per share and (ii) the Class C Share Voting Amount on all matters submitted to stockholders for their vote or approval.

------

From and after the Sunset Date, holders of Class C Common Stock will be entitled to one vote per share. Class C common stock does not have any of the economic rights (including rights to dividends and distributions upon liquidation) associated with Class A common stock.

(3)Each warrant entitles the registered holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment.

(4)Mr. Sacks is the ultimate managing member of each of (i) Holdings, (ii) Management LLC, (iii) Holdings II, and (iv) GCM Progress Subsidiary LLC, a Delaware limited liability company (collectively, the "GCMH Equityholders"). Any distribution of proceeds derived from the securities held by the GCMH Equityholders is shared among the respective members of such entities in accordance with the applicable operating agreements of such entities.

(5)As of August 4, 2025, there were 53,220,319 shares of Class A common stock outstanding and 141,665,831 common units of GCMH ("Common Units") outstanding held by the GCMH Equityholders, which may be exchanged for shares of Class A common stock on a one-to-one basis, or, at the Company's election, for cash, pursuant to and subject to the restrictions set forth in the Fifth Amended and Restated Limited Liability Limited Partnership Agreement of GCMH. As of August 4, 2025, GCM V held 141,665,831 shares of Class C common stock, which corresponds to the number of Common Units held by the GCMH Equityholders.

**Components of Results of Operations**

**Revenues**

We generate revenues from management fees and incentive fees, which includes carried interest and performance fees.

***Management Fees***

*Management Fees*

We earn management fees from providing investment management services to specialized funds and customized separate account clients. Specialized funds are generally structured as partnerships or companies having multiple investors. Customized separate account clients may be structured using an affiliate-managed entity or may involve an investment management agreement between us and a single client. Certain separate account clients may have us manage assets both with full discretion over investments decisions as well as without discretion over investment decisions and may also receive access to various other advisory services the firm may provide.

Certain of our management fees, typically associated with our private markets strategies, are based on client commitments to those funds during an initial commitment or investment period. During this period, fees may be charged on total commitments, on invested capital (capital committed to underlying investments) or on a ratable ramp-in of total commitments, which is meant to mirror typical invested capital pacing. Following the expiration or termination of such period, certain fees continue to be based on client commitments while others are based on invested assets or based on invested capital and unfunded deal commitments less returned capital or based on a fixed ramp down schedule.

Certain of our management fees, typically associated with absolute return strategies, are based on the NAV of those funds. Such GCM Funds either have a set fee for the entire fund or a fee scale through which clients with larger commitments pay a lower fee.

Management fees are determined quarterly and are more commonly billed in advance based on the management fee rate applied to the management fee base at the end of the preceding quarterly period as defined in the respective contractual agreements.

We provided investment management / advisory services on assets of $85.9 billion and $80.1 billion as of June 30, 2025 and December 31, 2024, respectively.

*Fund expense reimbursement revenue*

We incur certain costs, primarily related to accounting, client reporting, investment-decision making and treasury-related expenditures, for which we receive reimbursement from the GCM Funds in connection with our performance obligations to provide investment management services. We concluded that we control the services provided and resources used before they are transferred to the customer, and therefore we act as a principal. Accordingly, the reimbursement for these costs incurred by us are presented on a gross basis within management fees. Expense reimbursements are recognized at a point in time, in the periods during which the related expenses are incurred and the reimbursements are contractually earned.

***Incentive Fees***

Incentive fees are based on the results of our funds, in the form of performance fees and carried interest income, which together comprise incentive fees.

------

*Carried Interest*

Carried interest is a performance-based capital allocation from a fund's limited partners earned by us in certain GCM Funds, more commonly in private markets strategies. Carried interest is typically a percentage of the profits calculated in accordance with the terms of fund agreements, certain fees and a preferred return to the fund's limited partners. Carried interest is ultimately realized when underlying investments distribute proceeds or are sold and therefore carried interest is highly susceptible to market factors, judgments, and actions of third parties that are outside of our control.

Agreements generally include a clawback provision that, if triggered, would require us to return up to the cumulative amount of carried interest distributed, typically net of tax, upon liquidation of those funds, if the aggregate amount paid as carried interest exceeds the amount actually due based upon the aggregate performance of each fund. We have defined the portion to be deferred as the amount of carried interest, typically net of tax, that we would be required to return if all remaining investments had no value as of the end of each reporting period. As of June 30, 2025, deferred revenue relating to constrained realized carried interest was approximately $6.1 million.

Assets under management that are subject to carried interest, excluding investments of the firm and our professionals from which we generally do not earn incentive fees, were approximately $47.4 billion as of June 30, 2025.

*Performance Fees*

We may receive performance fees from certain GCM Funds, more commonly in funds associated with absolute return strategies. Performance fees are typically a fixed percentage of investment gains, subject to loss carryforward provisions that require the recapture of any previous losses before any performance fees can be earned in the current period. Performance fees may or may not be subject to a hurdle or a preferred return, which requires that clients earn a specified minimum return before a performance fee can be assessed. These performance fees are determined based upon investment performance at the end of a specified measurement period, generally the end of the calendar year.

Investment returns are highly susceptible to market factors, judgments, and actions of third parties that are outside of our control. Accordingly, performance fees are variable consideration and are therefore constrained and not recognized until it is probable that a significant reversal will not occur. In the event that a client redeems from one of the GCM Funds prior to the end of a measurement period, any accrued performance fee is ordinarily due and payable by such redeeming client as of the date of the redemption.

Assets under management that are subject to performance fees, excluding investments of the firm and our professionals from which we generally do not earn incentive fees, were approximately $14.3 billion as of June 30, 2025.

***Other Operating Income***

Other operating income primarily consists of administrative fees from certain private investment vehicles where we perform a full suite of administrative functions but do not manage or advise and have no discretion over the capital.

**Expenses**

***Employee Compensation and Benefits***

Employee compensation and benefits primarily consists of (1) cash-based employee compensation and benefits, (2) equity-based compensation, (3) partnership interest-based compensation, (4) carried interest compensation, (5) cash-based incentive fee related compensation and (6) other non-cash compensation. Bonus and incentive fee related compensation is generally determined by our management and is discretionary taking into consideration, among other things, our financial results and the employee's performance. In addition, various individuals, including certain senior professionals have been awarded partnership interests and/or restricted stock units ("RSUs"). These partnership interests grant the recipient the right to certain cash distributions from GCMH Equityholders' profits (to the extent such distributions are authorized) and/or to certain net sale proceeds after threshold distributions, resulting in non-cash profits interest compensation expense. The company recognizes compensation expense attributable to the RSUs on a straight-line basis over the requisite service period, which is generally the vesting period. Certain employees and former employees are also entitled to a portion of the carried interest and performance fees realized from certain GCM Funds, which is payable upon a realization of the carried interest or performance fees.

------

***General, Administrative and Other***

General, administrative and other consists primarily of professional fees, travel and related expenses, IT operations, communications and information services, occupancy, fund expenses, depreciation and amortization, and other costs associated with our operations.

**Net Other Income (Expense)**

***Investment Income (Loss)***

Investment income (loss) primarily consists of gains and losses arising from our equity method investments.

***Interest Expense***

Interest expense includes interest paid and accrued on our outstanding debt, along with the amortization of deferred debt issuance costs incurred from debt issued by us, including the Term Loan Facility and the Revolving Credit Facility (each of which defined below) entered into by us. Interest expense also includes (1) the impact of qualifying effective cash flow hedges and (2) the amortization of realized gains or losses on interest rate swaps that initially qualified for hedge accounting and were subsequently terminated. The unrealized gains or losses are reclassified from accumulated other comprehensive income into interest expense over the original life of the swap for terminated derivative instruments.

***Other Income (Expense)***

Other income (expense) consists primarily of other non-operating items, including interest income.

***Change in Fair Value of Warrant Liabilities***

Change in fair value of warrant liabilities are non-cash and consist of fair value adjustments related to the outstanding public and private warrants issued in connection with the Transaction. The warrant liabilities are classified as marked-to-market liabilities pursuant to ASC 815-40, *Derivatives and Hedging—Contracts in Entity's Own Equity*, and the corresponding increase or decrease in value impacts our net income (loss).

**Provision for Income Taxes**

We are a corporation for U.S. federal income tax purposes and therefore are subject to U.S. federal and state income taxes on our share of taxable income generated by us and our subsidiaries. GCMH is treated as a pass-through entity for U.S. federal and state income tax purposes. As such, income generated by GCMH flows through to its partners, and is generally not subject to U.S. federal or state income tax at the partnership level. Our non-U.S. subsidiaries generally operate as corporate entities in non-U.S. jurisdictions, with certain of these entities subject to local or non-U.S. income taxes. The tax liability with respect to income attributable to noncontrolling interests in GCMH is borne by the holders of such noncontrolling interests**.**

**Net Income (Loss) Attributable to Noncontrolling Interests**

Net income attributable to noncontrolling interests in subsidiaries represents the economic interests of third parties in certain consolidated subsidiaries.

Net income (loss) attributable to noncontrolling interests in GCMH represents the economic interests of GCMH Equityholders in GCMH. Profits and losses, other than partnership interest-based compensation, are allocated to the noncontrolling interests in GCMH in proportion to their relative ownership interests regardless of their basis.

------

**Results of Operations** 

The following is a discussion of our consolidated results of operations for the three and six months ended June 30, 2025 and 2024. This information is derived from our accompanying Condensed Consolidated Financial Statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| **Revenues** |  |  |  |  |
| Management fees | $101924 | $99843 | $211239 | $195728 |
| Incentive fees | 16258 | 16037 | 31326 | 26155 |
| Other operating income | 1475 | 1074 | 2938 | 3937 |
| &nbsp;&nbsp;&nbsp;Total operating revenues | 119657 | 116954 | 245503 | 225820 |
| **Expenses** |  |  |  |  |
| Employee compensation and benefits | 74863 | 67955 | 157103 | 167602 |
| General, administrative and other | 25549 | 28164 | 53825 | 53343 |
| &nbsp;&nbsp;&nbsp;Total operating expenses | 100412 | 96119 | 210928 | 220945 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income | 19245 | 20835 | 34575 | 4875 |
| Investment income | 5782 | 1290 | 6546 | 6967 |
| Interest expense | (5908) | (6134) | (11571) | (12057) |
| Other income | 1182 | 394 | 2028 | 947 |
| Change in fair value of warrant liabilities | 19388 | (180) | 10612 | (2324) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net other income (expense) | 20444 | (4630) | 7615 | (6467) |
| Income (loss) before income taxes | 39689 | 16205 | 42190 | (1592) |
| Provision (benefit) for income taxes | (202) | 3244 | 3389 | 4354 |
| &nbsp;&nbsp;&nbsp;Net income (loss) | 39891 | 12961 | 38801 | (5946) |
| Less: Net income (loss) attributable to noncontrolling interests in subsidiaries | 980 | (901) | 1155 | 401 |
| Less: Net income (loss) attributable to noncontrolling interests in GCMH | 23474 | 9062 | 21746 | (13271) |
| &nbsp;&nbsp;&nbsp;Net income attributable to GCM Grosvenor Inc. | $15437 | $4800 | $15900 | $6924 |

---

**Revenues** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| &nbsp;&nbsp;Private markets strategies | $59600 | $58807 | $126458 | $114384 |
| &nbsp;&nbsp;Absolute return strategies | 38334 | 37690 | 76109 | 74065 |
| &nbsp;&nbsp;Fund expense reimbursement revenue | 3990 | 3346 | 8672 | 7279 |
| Total management fees | 101924 | 99843 | 211239 | 195728 |
| Incentive fees | 16258 | 16037 | 31326 | 26155 |
| &nbsp;&nbsp;Administrative fees | 1295 | 954 | 2577 | 1896 |
| &nbsp;&nbsp;Other | 180 | 120 | 361 | 2041 |
| Total other operating income | 1475 | 1074 | 2938 | 3937 |
| Total operating revenues | $119657 | $116954 | $245503 | $225820 |

---

------

*Three Months Ended June 30, 2025 and June 30, 2024* 

Management fees increased $2.1 million, or 2%, to $101.9 million for the three months ended June 30, 2025 compared to the three months ended June 30, 2024. Private markets strategies fees increased $0.8 million, or 1%, primarily due to a $0.3 million increase in private market strategies specialized funds fees and a $0.5 million increase in private markets strategies customized separate accounts fees, both as a result of capital raising and deployment. Absolute return strategies fees increased $0.6 million, or 2%, primarily as a result of capital raising and higher returns for certain absolute return strategies funds. Fund expense reimbursement revenue increased $0.6 million, or 19% to $4.0 million.

Incentive fees consisted of carried interest and performance fees. Carried interest increased $3.1 million, or 27%, to $14.8 million for the three months ended June 30, 2025 compared to the three months ended June 30, 2024. This increase is primarily due to higher distributions from investments and tax carry realizations during three months ended June 30, 2025, as compared to the three months ended June 30, 2024. Performance fees decreased $2.9 million, or 67%, to $1.4 million, for the three months ended June 30, 2025 compared to the three months ended June 30, 2024, primarily due to lower returns from absolute return strategies funds with a different fiscal year than us. Performance fees are generally determined at the end of the calendar year and are generally minimal in interim periods.

*Six Months Ended June 30, 2025 and June 30, 2024*

Management fees increased $15.5 million, or 8%, to $211.2 million for the six months ended June 30, 2025 compared to the six months ended June 30, 2024. Private market strategies fees increased $12.1 million, or 11%, primarily due to a $11.4 million increase in private market strategies specialized funds fees and a $0.8 million increase in private market strategies customized separate accounts fees, both as a result of capital raising and deployment. Absolute return strategies fees increased $2.0 million, or 3%, primarily as a result of capital raising and higher returns for certain absolute return strategies funds. Fund expense reimbursement revenue increased $1.4 million, or 19% to $8.7 million.

Incentive fees consisted of carried interest and performance fees. Carried interest increased $10.3 million, or 65%, to $26.1 million for the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to higher distributions from investments and carry realizations and higher tax carry realizations related to 2024 taxable income during the six months ended June 30, 2025, as compared to the six months ended June 30, 2024. Performance fees decreased $5.1 million, or 49%, to $5.3 million for the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to lower fees earned from funds with a different fiscal year than us. Performance fees are generally determined at the end of the calendar year and are generally minimal in interim periods.

**Expenses**

***Employee Compensation and Benefits***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| Cash-based employee compensation and benefits | $38658 | $38733 | $77705 | $76006 |
| Equity-based compensation | 6776 | 5335 | 27077 | 30805 |
| Partnership interest-based compensation | 16323 | 11588 | 28548 | 41590 |
| Carried interest compensation | 9281 | 6860 | 14606 | 9402 |
| Cash-based incentive fee related compensation | 3832 | 5260 | 8990 | 9449 |
| Other non-cash compensation | (7) | 179 | 177 | 350 |
| Total employee compensation and benefits | $74863 | $67955 | $157103 | $167602 |

---

*Three Months Ended June 30, 2025 and June 30, 2024*

Employee compensation and benefits increased $6.9 million, or 10%, for the three months ended June 30, 2025 compared to the three months ended June 30, 2024. The overall increase was primarily driven by an increase in partnership interest-based compensation and carried interest compensation. Partnership interest-based compensation increased $4.7 million, or 41%, primarily due to award modifications during the second quarter of 2025. This was partially offset by lower expense of the Holdings Awards that were granted in 2023 and were fully expensed during the year ended December 31, 2024, and the GCMH Equityholders Awards that were granted in 2022 and were fully expensed during the six months ended June 30, 2025.

------

Holdings Awards and GCMH Equityholders Awards are further described in Note 9 in the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of the Quarterly Report on Form 10-Q). These awards do not dilute Class A common stockholders or impact our net cash flows. Carried interest compensation increased $2.4 million, or 35%, primarily due to higher realized carried interest during the three months ended June 30, 2025 compared to the three months ended June 30, 2024.

*Six Months Ended June 30, 2025 and June 30, 2024*

Employee compensation and benefits decreased $10.5 million, or 6%, for the six months ended June 30, 2025 compared to the six months ended June 30, 2024. The overall decrease was primarily driven by decreases in partnership interest-based compensation partially offset by an increase in carried interest compensation. Partnership interest-based compensation decreased $13.0 million, or 31%, primarily due to award modifications that occurred in the first quarter of 2024 and expenses recorded for the Holdings Awards and GCMH Equityholders Awards for the six months ended June 30, 2024. Holdings Awards did not have any expense recorded for the six months ended June 30, 2025 as they were fully expensed during the year ended December 31, 2024. GCMH Equityholders Awards were fully expensed during the six months ended June 30, 2025. Holdings Awards and GCMH Equityholders Awards are further described in Note 9 in the Notes to Condensed Consolidated Financial Statements included in Part I, Item 2 of the Quarterly Report on Form 10-Q. These awards do not dilute Class A common stockholders or impact our net cash flows. Carried interest compensation increased $5.2 million, or 55%, primarily due to higher realized carried interest during the six months ended June 30, 2025.

***General, Administrative and Other***

*Three and Six Months Ended June 30, 2025 and June 30, 2024*

General, administrative and other decreased $2.6 million, or 9%, to $25.5 million for the three months ended June 30, 2025 compared to the three months ended June 30, 2024, primarily driven by a decrease in professional fees of $2.5 million and rent expense of $1.2 million, partially offset by an increase travel related costs of $0.9 million.

General, administrative and other increased $0.5 million, or 1%, to $53.8 million for the six months ended June 30, 2025 compared to the six months ended June 30, 2024, primarily due to increases in travel related costs of $1.3 million and depreciation expense of $0.9 million, partially offset by a decrease in occupancy expenses of $2.1 million.

**Net Other Income (Expense)**

*Three Months Ended June 30, 2025 and June 30, 2024*

Investment income was $5.8 million for the three months ended June 30, 2025 compared to $1.3 million for the three months ended June 30, 2024, the change was primarily due to the change in value of private and public market investments.

Interest expense was $5.9 million for the three months ended June 30, 2025, which was generally consistent with interest expense of $6.1 million for the three months ended June 30, 2024.

Other income was $1.2 million for the three months ended June 30, 2025, compared to other income of $0.4 million for the three months ended June 30, 2024, and consisted primarily of interest income in each period.

Change in fair value of warrant liabilities of $19.4 million for the three months ended June 30, 2025 was due to a decrease in the fair value of the warrants from March 31, 2025 to June 30, 2025.

*Six Months Ended June 30, 2025 and June 30, 2024*

Investment income was $6.5 million for the six months ended June 30, 2025 compared to $7.0 million for the six months ended June 30, 2024, primarily due to the change in value of private and public market investments.

Interest expense of $11.6 million for the six months ended June 30, 2025 was generally consistent with the interest expense of $12.1 million for the six months ended June 30, 2024.

Other income was $2.0 million for the six months ended June 30, 2025 compared to $0.9 million for the six months ended June 30, 2024, and consisted primarily of interest income in each period.

------

Change in fair value of warrant liabilities of $10.6 million for the six months ended June 30, 2025 was due to a decrease in the fair value of the warrants from December 31, 2024 to June 30, 2025.

**Provision for Income Taxes** 

*Three and Six Months Ended June 30, 2025 and June 30, 2024*

Provision for income taxes primarily reflect U.S. federal and state income taxes on our share of taxable income generated by us, as well as local and foreign income taxes of certain of the our subsidiaries.

Our effective tax rate was (1)% and 20% for the three months ended June 30, 2025 and 2024, respectively, and 8% and (273)% for the six months ended June 30, 2025 and 2024, respectively. Our overall effective tax rate was greater than the statutory rate primarily due to the portion of income allocated to the noncontrolling interest holders, including profit interest expense, as well as a valuation allowance recorded against deferred tax assets and discrete tax adjustments recorded in the periods.

**Net Income (Loss) Attributable to Noncontrolling Interests**

*Three and Six Months Ended June 30, 2025 and June 30, 2024*

Net income (loss) attributable to noncontrolling interests in subsidiaries was $1.0 million and $(0.9) million for the three months ended June 30, 2025 and 2024, respectively, and $1.2 million and $0.4 million for the six months ended June 30, 2025 and 2024, respectively. The increase for the three and six months ended June 30, 2025, as compared to the three and six months ended June 30, 2024, was primarily attributable to an increase in income generated by our consolidated subsidiaries not wholly owned by us.

Net income (loss) attributable to noncontrolling interests in GCMH was $23.5 million and $9.1 million for the three months ended June 30, 2025 and 2024, respectively, and $21.7 million and $(13.3) million for the six months ended June 30, 2025 and 2024, respectively. The change in net income (loss) attributable to noncontrolling interests in GCMH for the three and six months ended June 30, 2025, as compared to the three and six months ended June 30, 2024, was primarily attributable to an increase and decrease in partnership-interest based compensation for the three and six months ended June 30, 2025, respectively, which was fully allocated to noncontrolling interest in GCMH .

**Fee-Paying AUM** 

FPAUM is a metric we use to measure the assets from which we earn management fees. Our FPAUM comprises the assets in our customized separate accounts and specialized funds from which we derive management fees. We classify customized separate account revenue as management fees if the client is charged an asset-based fee, which includes the vast majority of our discretionary AUM accounts. Our FPAUM for private market strategies typically represents committed, invested or scheduled capital during the investment period and invested capital following the expiration or termination of the investment period. Substantially all of our private markets strategies funds earn fees based on commitments or net invested capital, which are not affected by market appreciation or depreciation. Our FPAUM for our absolute return strategy is based on NAV, which includes impacts of any market appreciation or depreciation.

Our calculations of FPAUM may differ from the calculations of other asset managers, and as a result, this measure may not be comparable to similar measures presented by other asset managers. Our definition of FPAUM is not based on any definition that is set forth in the agreements governing the customized separate accounts or specialized funds that we manage.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Three Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** | **Six Months Ended June 30, 2025** |
| (in millions, unaudited) | **Private Markets Strategies** | **Absolute Return Strategies** | **Total FPAUM** | **Private<br>Markets<br>Strategies** | **Absolute<br>Return<br>Strategies** | **Total FPAUM** |
| Fee-paying AUM |  |  |  |  |  |  |
| Balance, beginning of period | $44398 | $22001 | $66399 | $42717 | $22048 | $64765 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contributions | 1342 | 650 | 1992 | 3707 | 977 | 4684 |
| &nbsp;&nbsp;&nbsp;&nbsp;Withdrawals | (52) | (141) | (193) | (79) | (517) | (596) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributions | (530) | (69) | (599) | (1045) | (78) | (1123) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in market value | 25 | 1088 | 1113 | 53 | 1065 | 1118 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange and other | 278 | 83 | 361 | 108 | 117 | 225 |
| Balance, end of period | $45461 | $23612 | $69073 | $45461 | $23612 | $69073 |

---

Contracted, not yet fee-paying AUM ("CNYFPAUM") represents limited partner commitments which are expected to be invested and begin charging fees over the ensuing five years.

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| (in millions) | **June 30, 2025** | **December 31, 2024** |
| Contracted, not yet Fee-Paying AUM | $8748 | $8202 |
| AUM | $85931 | $80077 |

---

Of the $8.7 billion CNYFPAUM as of June 30, 2025, approximately $2.3 billion is subject to an agreed upon fee ramp in schedule. The ramp in schedule will result in management fees being charged on approximately $0.3 billion, $0.8 billion and $1.2 billion of such amount in the remainder of 2025, in 2026, and in 2027 and beyond, respectively. Management fees will be charged on the remaining approximately $6.4 billion of CNYFPAUM as such capital is invested, which will depend on a number of factors, including the availability of eligible investment opportunities.

*Three Months Ended June 30, 2025*

FPAUM increased $2.7 billion, or 4%, to $69.1 billion during the three months ended June 30, 2025 due to $2.0 billion of contributions and a $1.1 billion increase in market value, respectively, partially offset by $0.6 billion of distributions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Private markets strategies FPAUM increased $1.1 billion, or 2%, to $45.5 billion during the three months ended June 30, 2025, primarily due to $1.3 billion of contributions, partially offset by $0.5 billion of distributions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Absolute return strategies FPAUM increased $1.6 billion, or 7%, to $23.6 billion during the three months ended June 30, 2025, primarily due to a $1.1 billion increase in market value and $0.7 billion of contributions, respectively, and partially offset by $0.1 billion of withdrawals.

CNYFPAUM increased $0.5 billion, or 6%, to $8.7 billion during the three months ended June 30, 2025 due to the closing of new commitments during the period, net of reductions for CNYFPAUM that became FPAUM during the period.

AUM increased $4.0 billion, or 5%, to $85.9 billion during the three months ended June 30, 2025, primarily driven by a $2.7 billion increase in FPAUM and a $0.5 billion increase in CNYFPAUM, as well as mark to market increases that do not impact FPAUM.

*Six Months Ended June 30, 2025*

FPAUM increased $4.3 billion, or 7%, to $69.1 billion during the six months ended June 30, 2025, primarily due to $4.7 billion of contributions and a $1.1 billion increase in market value, offset by $0.6 billion and $1.1 billion of withdrawals and distributions, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Private markets strategies FPAUM increased $2.7 billion, or 6%, to $45.5 billion during the six months ended June 30, 2025, primarily due to $3.7 billion of contributions, partially offset by $1.0 billion of distributions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Absolute return strategies FPAUM increased $1.6 billion, or 7%, to $23.6 billion during the six months ended June 30, 2025, primarily due to a $1.1 billion increase in market value and $1.0 billion of contributions, respectively, partially offset by $0.5 billion of withdrawals.

------

CNYFPAUM increased $0.5 billion, or 7%, to $8.7 billion during the six months ended June 30, 2025 due to the closing of new commitments during the period, net of reductions for CNYFPAUM that became FPAUM during the period.

AUM increased $5.9 billion, or 7%, to $85.9 billion during the six months ended June 30, 2025, primarily driven by a $4.3 billion increase in FPAUM and a $0.5 billion increase in CNYFPAUM, as well as mark to market increases that do not impact FPAUM.

**Non-GAAP Financial Measures**

In addition to our results of operations above, we report certain financial measures that are not required by, or presented in accordance with, GAAP. Management uses these non-GAAP measures to assess the performance of our business across reporting periods and believes this information is useful to investors for the same reasons. These non-GAAP measures should not be considered a substitute for the most directly comparable GAAP measures, which are reconciled below. Further, these measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these measurements in isolation or as a substitute for GAAP measures including revenues and net income (loss). We may calculate or present these non-GAAP financial measures differently than other companies who report measures with the same or similar names, and as a result, the non-GAAP measures we report may not be comparable.

**Summary of Non-GAAP Financial Measures** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| **Revenues** |  |  |  |  |
| &nbsp;&nbsp;Private markets strategies<sup>(1)</sup> | $60148 | $58807 | $127073 | $114384 |
| &nbsp;&nbsp;Absolute return strategies<sup>(1)</sup> | 38334 | 37690 | 76109 | 74065 |
| Management fees, net | 98482 | 96497 | 203182 | 188449 |
| Administrative fees and other operating income | 1475 | 1074 | 2938 | 3937 |
| **Fee-Related Revenue** | 99957 | 97571 | 206120 | 192386 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;Cash-based employee compensation and benefits, net<sup>(2)</sup> | (37134) | (38103) | (75231) | (75090) |
| &nbsp;&nbsp;General, administrative and other, net<sup>(3)</sup> | (21206) | (20219) | (42615) | (39923) |
| **Fee-Related Earnings** | 41617 | 39249 | 88274 | 77373 |
| Fee-Related Earnings Margin<sup>(4)</sup> | 42% | 40% | 43% | 40% |
| Incentive fees: |  |  |  |  |
| &nbsp;&nbsp;Performance fees | 1433 | 4346 | 5251 | 10333 |
| &nbsp;&nbsp;Carried interest | 14825 | 11691 | 26075 | 15822 |
| Incentive fee related compensation and NCI: |  |  |  |  |
| &nbsp;&nbsp;Cash-based incentive fee related compensation | (3832) | (5260) | (8990) | (9449) |
| &nbsp;&nbsp;Carried interest compensation, net<sup>(5)</sup> | (8564) | (6805) | (14583) | (9356) |
| &nbsp;&nbsp;Carried interest attributable to noncontrolling interests | (1306) | (466) | (1758) | (1051) |
| Realized investment income, net of amount attributable to noncontrolling interests in subsidiaries<sup>(6)</sup> | 3339 | 1853 | 5092 | 2444 |
| Interest income | 1019 | 577 | 1899 | 1156 |
| Other (income) expense | 163 | (26) | 129 | (52) |
| Depreciation | 822 | 315 | 1503 | 620 |
| **Adjusted EBITDA** | 49516 | 45474 | 102892 | 87840 |
| &nbsp;&nbsp;Depreciation | (822) | (315) | (1503) | (620) |
| &nbsp;&nbsp;Interest expense | (5908) | (6134) | (11571) | (12057) |
| **Adjusted Pre-Tax Income** | 42786 | 39025 | 89818 | 75163 |
| &nbsp;&nbsp;Adjusted income taxes<sup>(7)</sup> | (10696) | (9639) | (22454) | (18565) |
| **Adjusted Net Income** | $32090 | $29386 | $67364 | $56598 |

---

------

____________

(1)Excludes fund expense reimbursement revenue, net of $3.2 million and $3.3 million, for the three months ended June 30, 2025 and 2024, respectively, and $7.8 million and $7.3 million for the six months ended June 30, 2025 and 2024, respectively, and excludes net revenue of noncontrolling interests of $0.2 million and $0.3 million in a consolidated subsidiary for the three and six months ended June 30, 2025, respectively. There was no net revenue of noncontrolling interests in a consolidated subsidiary for each of the three and six months ended June 30, 2024.

(2)Excludes severance expense of $1.5 million and $0.6 million for the three months ended June 30, 2025 and 2024, respectively, and $2.6 million and $0.9 million for the six months ended June 30, 2025 and 2024, respectively.

(3)Excludes amortization of intangibles of $0.3 million for each of the three months ended June 30, 2025 and 2024, and $0.7 million for each of the six months ended June 30, 2025 and 2024. Also excludes $0.1 million and $1.6 million for the three and six months ended June 30, 2025, respectively, of completed and contemplated corporate transaction related costs, and $3.1 million and $3.2 million for the three and six months ended June 30, 2024 of debt amendment and extension expenses, respectively. Also excludes other non-core expenses of $0.7 million and $1.2 million for the three months ended June 30, 2025 and 2024, respectively, and $1.1 million and $2.3 million for the six months ended June 30, 2025 and 2024, respectively. Non-core expenses include office relocation costs of $0.9 million and $1.8 million for the three and six months ended June 30, 2024, respectively. Also, excludes fund reimbursement expenses related to general, administrative, and other of $3.2 million and $3.3 million for the three months ended June 30, 2025 and 2024, respectively, and $7.9 million and $7.3 million for the six months ended June 30, 2025 and 2024, respectively.

(4)Fee-related earnings margin represents fee-related earnings as a percentage of our fee-related revenue.

(5)Excludes the impact of non-cash carried interest compensation and other of $0.7 million and de minimis for the three and six months ended June 30, 2025. The net non-cash carried interest compensation and other for the three and six months ended June 30, 2024 was de minimis.

(6)Investment income or loss is generally realized when we redeem all or a portion of our investment or when we receive or is due cash, such as a from dividends or distributions.

(7)Represents corporate income taxes at a blended statutory rate of 25.0% and 24.7% applied to Adjusted Pre-Tax Income for the three and six months ended June 30, 2025 and 2024, respectively. The 25.0% and 24.7% are based on a federal statutory rate of 21.0% and a combined state, local and foreign rate net of federal benefits of 4.0% and 3.7%, respectively.

**Net Incentive Fees Attributable to GCM Grosvenor** 

Net Incentive Fees Attributable to GCM Grosvenor is a non-GAAP measure used to highlight fees earned from incentive fees that are attributable to GCM Grosvenor. Net Incentive Fees Attributable to GCM Grosvenor represent incentive fees excluding (a) incentive fees contractually owed to others and (b) cash-based incentive fee related compensation. Net incentive fees provide investors useful information regarding the amount that such fees contribute to our earnings and are used by management in making compensation and capital allocation decisions.

The following table shows reconciliations of incentive fees to Net Incentive Fees Attributable to GCM Grosvenor for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| Incentive fees: |  |  |  |  |
| &nbsp;&nbsp;Performance fees | $1433 | $4346 | $5251 | $10333 |
| &nbsp;&nbsp;Carried interest | 14825 | 11691 | 26075 | 15822 |
| Less incentive fees contractually owed to others: |  |  |  |  |
| &nbsp;&nbsp;Cash carried interest compensation | (9281) | (6860) | (14606) | (9402) |
| &nbsp;&nbsp;Non-cash carried interest compensation and other | 717 | 55 | 23 | 46 |
| &nbsp;&nbsp;Carried interest attributable to other noncontrolling interest holders | (1306) | (466) | (1758) | (1051) |
| Firm share of incentive fees<sup>(1)</sup> | 6388 | 8766 | 14985 | 15748 |
| &nbsp;&nbsp;Less: Cash-based incentive fee related compensation | (3832) | (5260) | (8990) | (9449) |
| Net Incentive Fees Attributable to GCM Grosvenor | $2556 | $3506 | $5995 | $6299 |

---

____________

(1)Firm share of incentive fees represents incentive fees net of contractual obligations but before discretionary cash-based incentive compensation.

------

**Adjusted Pre-Tax Income, Adjusted Net Income and Adjusted EBITDA** 

Adjusted Pre-Tax Income, Adjusted Net Income and Adjusted EBITDA are non-GAAP measures used to evaluate our profitability.

Adjusted Net Income is a non-GAAP measure that we present on a pre-tax and after-tax basis to evaluate our profitability. Adjusted Pre-Tax Income represents net income attributable to GCM Grosvenor Inc. including (a) net income (loss) attributable to GCMH, excluding (b) provision (benefit) for income taxes, (c) changes in fair value of warrant liabilities, (d) amortization expense, (e) partnership interest-based and non-cash compensation, (f) equity-based compensation, including cash-settled equity awards (as we view the cash settlement as a separate capital transaction), (g) unrealized investment income, (h) changes in tax receivable agreement liability and (i) certain other items that we believe are not indicative of our core performance, including charges related to completed and corporate transactions, employee severance, office relocation costs, and loss on extinguishment of debt. Adjusted Net Income represents Adjusted Pre-Tax Income fully taxed at each period's blended statutory tax rate.

Adjusted EBITDA is a non-GAAP measure which represents Adjusted Net Income excluding (a) adjusted income taxes, (b) depreciation and amortization expense and (c) interest expense on our outstanding debt.

We are a holding company with no material assets other than its indirect ownership of equity interests in GCMH and certain deferred tax assets. The GCMH Equityholders may from time to time cause GCMH to redeem any or all of their GCMH common units in exchange, at our election, for either cash (based on the market price for a share of the Class A common stock) or shares of Class A common stock. As such, net income (loss) attributable to noncontrolling interests in GCMH is added back in order to reflect the full economics of the underlying business as if GCMH Equityholders converted their interests to shares of Class A common stock. Other noncontrolling interests do not have the ability to convert those interests into our equity interests, and as such, income (loss) attributable to these noncontrolling interests are not adjusted for in our non-GAAP financial measures.

We believe Adjusted Pre-Tax Income, Adjusted Net Income and Adjusted EBITDA are useful to investors because they provide additional insight into the operating profitability of our core business across reporting periods. These measures (1) present a view of the economics of the underlying business as if GCMH Equityholders converted their interests to shares of Class A common stock and (2) adjust for certain non-cash and other activity in order to provide more comparable results of the core business across reporting periods. These measures are used by management in budgeting, forecasting and evaluating operating results.

------

The following table shows reconciliations of net income attributable to GCM Grosvenor Inc. and Adjusted Pre-Tax Income, Adjusted Net Income and Adjusted EBITDA for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| **Adjusted Pre-Tax Income & Adjusted Net Income** |  |  |  |  |
| Net income attributable to GCM Grosvenor Inc. | $15437 | $4800 | $15900 | $6924 |
| Plus: |  |  |  |  |
| &nbsp;&nbsp;Net income (loss) attributable to noncontrolling interests in GCMH | 23474 | 9062 | 21746 | (13271) |
| &nbsp;&nbsp;Provision (benefit) for income taxes | (202) | 3244 | 3389 | 4354 |
| &nbsp;&nbsp;Change in fair value of warrant liabilities | (19388) | 180 | (10612) | 2324 |
| &nbsp;&nbsp;Amortization expense | 330 | 329 | 658 | 657 |
| &nbsp;&nbsp;Severance | 1524 | 630 | 2628 | 916 |
| &nbsp;&nbsp;Transaction expenses<sup>(1)</sup> | 101 | 3103 | 1555 | 3159 |
| &nbsp;&nbsp;Loss on extinguishment of debt |  | 157 |  | 157 |
| &nbsp;&nbsp;Changes in TRA liability and other<sup>(2)</sup> | 14 | 893 | 65 | 1896 |
| &nbsp;&nbsp;Partnership interest-based compensation | 16323 | 11588 | 28548 | 41590 |
| &nbsp;&nbsp;Equity-based compensation | 6776 | 5335 | 27077 | 30805 |
| &nbsp;&nbsp;Other non-cash compensation | (7) | 179 | 177 | 350 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;Unrealized investment income, net of noncontrolling interests | (2313) | (530) | (1336) | (4744) |
| &nbsp;&nbsp;Non-cash carried interest compensation and other | 717 | 55 | 23 | 46 |
| Adjusted Pre-Tax Income | 42786 | 39025 | 89818 | 75163 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;Adjusted income taxes<sup>(3)</sup> | (10696) | (9639) | (22454) | (18565) |
| Adjusted Net Income | $32090 | $29386 | $67364 | $56598 |
| **Adjusted EBITDA** |  |  |  |  |
| Adjusted Net Income | $32090 | $29386 | $67364 | $56598 |
| Plus: |  |  |  |  |
| &nbsp;&nbsp;Adjusted income taxes<sup>(3)</sup> | 10696 | 9639 | 22454 | 18565 |
| &nbsp;&nbsp;Depreciation expense | 822 | 315 | 1503 | 620 |
| &nbsp;&nbsp;Interest expense | 5908 | 6134 | 11571 | 12057 |
| Adjusted EBITDA | $49516 | $45474 | $102892 | $87840 |

---

____________

(1)Represents 2025 expenses related to completed and contemplated corporate transactions, and 2024 expenses incurred related to a debt amendment and extension.

(2)Includes $0.9 million and $1.8 million of office relocation costs for the three and six months ended June 30, 2024, respectively.

(3)Represents corporate income taxes at a blended statutory rate of 25.0% and 24.7% applied to Adjusted Pre-Tax Income for the three and six months ended June 30, 2025 and 2024, respectively. The 25.0% and 24.7% are based on a federal statutory rate of 21.0% and a combined state, local and foreign rate net of federal benefits of 4.0% and 3.7%, respectively.

------

**Adjusted Net Income Per Share** 

Adjusted Net Income Per Share is a non-GAAP measure that is calculated by dividing Adjusted Net Income by adjusted shares outstanding. Adjusted shares outstanding assumes the hypothetical full exchange of limited partnership interests in GCMH into Class A common stock of GCM Grosvenor Inc., the dilution from outstanding warrants for Class A common stock of GCM Grosvenor Inc. and the dilution from outstanding equity-based compensation. We believe adjusted net income per share is useful to investors because it enables them to better evaluate per-share performance across reporting periods.

The following table shows a reconciliation of diluted weighted-average shares of Class A common stock outstanding to adjusted shares outstanding used in the computation of adjusted net income per share for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, except share and per share amounts; unaudited)** | **(in thousands, except share and per share amounts; unaudited)** | **(in thousands, except share and per share amounts; unaudited)** | **(in thousands, except share and per share amounts; unaudited)** |
| **Adjusted Net Income Per Share** |  |  |  |  |
| Adjusted Net Income | $32090 | $29386 | $67364 | $56598 |
| Weighted-average shares of Class A common stock outstanding - basic | 51074156 | 44934623 | 48367585 | 44302442 |
| &nbsp;&nbsp;Exchange of partnership units | 142823480 | 144235246 | 143525463 | 144235246 |
| &nbsp;&nbsp;Exercise of private warrants - incremental shares under the treasury stock method | 63298 |  | 94589 |  |
| &nbsp;&nbsp;Exercise of public warrants - incremental shares under the treasury stock method | 1163618 |  | 1749494 |  |
| &nbsp;&nbsp;Assumed vesting of RSUs - incremental shares under the treasury stock method | 1214043 | 1008404 | 1904029 |  |
| Weighted-average shares of Class A common stock outstanding - diluted | 196338595 | 190178273 | 195641160 | 188537688 |
| &nbsp;&nbsp;Effect of RSUs, if antidilutive for GAAP |  |  |  | 1639536 |
| Adjusted shares | 196338595 | 190178273 | 195641160 | 190177224 |
| Adjusted Net Income Per Share | $0.16 | $0.15 | $0.34 | $0.30 |

---

**Fee-Related Revenue and Fee-Related Earnings**

Fee-Related Revenue ("FRR") is a non-GAAP measure used to highlight revenues from recurring management fees and administrative fees. FRR represents total operating revenues less (a) incentive fees, (b) net revenue of noncontrolling interests in consolidated subsidiary and (c) fund expense reimbursement revenue, net. We believe FRR is useful to investors because it provides additional insight into our relatively stable management fee base separate from incentive fee revenues, which tend to have greater variability.

Fee-Related Earnings ("FRE") is a non-GAAP measure used to highlight earnings from recurring management fees and administrative fees. FRE represents Adjusted EBITDA further adjusted to exclude (a) incentive fees, (b) other non-operating income, (c) depreciation expense and (d) realized investment income, net of amount attributable to noncontrolling interests in subsidiaries, and to include (a) incentive fee-related compensation and (b) carried interest attributable to other noncontrolling interest holders, net. We believe FRE is useful to investors because it provides additional insights into the management fee driven operating profitability of our business.

The following table shows reconciliations of Total Operating Revenues to Fee-Related Revenue for the three and six months ended June 30, 2025 and 2024:

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| **Fee Related Revenue** |  |  |  |  |
| Total Operating Revenues | $119657 | $116954 | $245503 | $225820 |
| &nbsp;&nbsp;Less: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive fees | (16258) | (16037) | (31326) | (26155) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fund expense reimbursement revenue, net | (3247) | (3346) | (7775) | (7279) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other adjustments<sup>(1)</sup> | (195) |  | $(282) | $— |
| Fee-Related Revenue | $99957 | $97571 | $206120 | $192386 |

---

____________

(1)Represents net revenue of noncontrolling interests in consolidated subsidiary

The following table shows reconciliations of Adjusted EBITDA to Fee-Related Earnings for the three and six months ended June 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| Adjusted EBITDA | $49516 | $45474 | $102892 | $87840 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;Incentive fees | (16258) | (16037) | (31326) | (26155) |
| &nbsp;&nbsp;Depreciation expense | (822) | (315) | (1503) | (620) |
| &nbsp;&nbsp;Other non-operating expense | (1182) | (551) | (2028) | (1104) |
| &nbsp;&nbsp;Realized investment income, net of amount attributable to noncontrolling interests in subsidiaries<sup>(1)</sup> | (3339) | (1853) | (5092) | (2444) |
| Plus: |  |  |  |  |
| &nbsp;&nbsp;Incentive fee-related compensation | 12396 | 12065 | 23573 | 18805 |
| &nbsp;&nbsp;Carried interest attributable to other noncontrolling interest holders, net | 1306 | 466 | 1758 | 1051 |
| Fee-Related Earnings | $41617 | $39249 | $88274 | $77373 |

---

____________

(1)Investment income or loss is generally realized when we redeem all or a portion of our investment or when we receive or are due cash, such as a from dividends or distributions.

**Liquidity and Capital Resources** 

We have historically financed our operations and working capital through net cash provided by operating activities and borrowings under our Term Loan Facility and Revolving Credit Facility (each as defined below). As of June 30, 2025, we had $136.3 million of cash and cash equivalents and available borrowing capacity of $50.0 million under our Revolving Credit Facility. On July 9, 2025, the SEC declared effective our Registration Statement on Form S-3, pursuant to which we may issue a combination of securities described in the prospectus in one or more offerings from time to time. Our primary cash needs are to fund working capital requirements, invest in growing our business, make investments in GCM Funds, make scheduled principal payments and interest payments on our outstanding indebtedness, pay dividends to holders of our Class A common stock, and pay tax distributions to members. Additionally, as a result of the Transaction, we need cash to make payments under the tax receivable agreement. We expect that our cash flow from operations, current cash and cash equivalents and available borrowing capacity under our Revolving Credit Facility will be sufficient to fund our operations and planned capital expenditures and to service our debt obligations for the next twelve months and the foreseeable future.

We are required to maintain minimum net capital balances for regulatory purposes for certain of our foreign subsidiaries as well as our U.S. broker-dealer subsidiary. These net capital requirements are met by retaining cash. As a result, we may be restricted in our ability to transfer cash between different operating entities and jurisdictions. As of June 30, 2025 we are in compliance with these regulatory requirements.

------

**<u>Cash Flow</u>** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** |
| | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
| Net cash provided by operating activities | $75241 | $41682 |
| Net cash used in investing activities | (7631) | (16497) |
| Net cash provided by (used in) financing activities | (22052) | 5664 |
| Effect of exchange rate changes on cash | 1322 | (1282) |
| Net increase in cash and cash equivalents | $46880 | $29567 |

---

**Net Cash Provided by Operating Activities**

Net cash provided by operating activities is generally comprised of our net income (loss) in the respective periods after adjusting for significant non-cash activities, including equity-based compensation for equity-classified awards, non-cash partnership interest-based compensation, the change in fair value of warrant liabilities, changes in payable to related parties pursuant to the tax receivable agreement and the change in equity value of our investments, all of which are included in earnings; proceeds received from return on investments; inflows for receipt of management and incentive fees; and outflows for operating expenses, including cash-based compensation; and lease liabilities.

Net cash provided by operating activities was $75.2 million and $41.7 million for the six months ended June 30, 2025 and 2024, respectively. These operating cash flows were primarily driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• net income of $82.6 million and $62.3 million for the six months ended June 30, 2025 and 2024, respectively, after adjusting for $43.8 million and $68.3 million of net non-cash activities for the six months ended June 30, 2025 and 2024, respectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decrease in working capital of $14.1 million during the six months ended June 30, 2025 as compared to $24.4 million in working capital during the six months ended June 30, 2024. The decrease is largely due to higher payments made for cash-based compensation, which were partially offset by an increase in collections related to incentive fees, during the six months ended June 30, 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• proceeds received from investments of $6.8 million and $3.7 million for the six months ended June 30, 2025 and 2024, respectively.

**Net Cash Used in Investing Activities**

Net cash used in investing activities was $(7.6) million and $(16.5) million for the six months ended June 30, 2025 and 2024, respectively. These investing cash flows were primarily driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• purchases of premises and equipment of $(2.4) million and $(8.9) million during the six months ended June 30, 2025 and 2024, respectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• contributions/subscriptions to investments of $(15.1) million and $(12.0) million during the six months ended June 30, 2025 and 2024, respectively; partially offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• distributions received from investments of $9.8 million and $4.4 million during the six months ended June 30, 2025 and 2024, respectively.

**Net Cash Used in Financing Activities**

Net cash provided by (used in) financing activities was $(22.1) million and $5.7 million for the six months ended June 30, 2025 and 2024, respectively. These financing cash flows were primarily driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• capital distributions paid to partners and member of $(38.3) million and $(15.9) million during the six months ended June 30, 2025 and 2024, respectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• capital distributions paid to noncontrolling interest holders of $(7.9) million and $(7.1) million during the six months ended June 30, 2025 and 2024, respectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• principal payments on the Term Loan Facility of $(2.2) million and $(1.0) million during each of the six months ended June 30, 2025 and 2024, respectively;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the settlement of equity-based compensation to satisfy withholding tax requirements of $(15.4) million and $(10.3) million during the six months ended June 30, 2025 and 2024, respectively; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• dividends paid of $(12.1) million and $(10.3) million during the six months ended June 30, 2025 and 2024, respectively; partially offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• proceeds from the Term Loan Facility amendment of $50.0 million during the six months ended June 30, 2024;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• proceeds from the exercise of warrants of $2.8 million during the six months ended June 30, 2025, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• proceeds from the Share Purchase Agreement, net of $49.8 million during the six months ended June 30, 2025.

**<u>Indebtedness</u>** 

On January 2, 2014, GCMH entered into a credit agreement (as amended, amended and restated, supplemented or otherwise modified, the "Credit Agreement") that provides GCMH with a senior secured term loan facility (the "Term Loan Facility") and a $50.0 million revolving credit facility (the "Revolving Credit Facility" and, together with the Term Loan Facility, the "Senior Secured Credit Facilities"). Under the Revolving Credit Facility, $15.0 million is available for letters of credit and $10.0 million is available for swingline loans.

On June 23, 2021, we amended our Term Loan Facility to increase the aggregate principal amount from $290.0 million to $400.0 million. On June 29, 2023, we entered into Amendment No. 7 to the Credit Agreement to incorporate changes for the contemplated transition to the Term Secured Overnight Financing Rate ("Term SOFR"), and on July 1, 2023, in conjunction with a Benchmark Transition Event, the interest rate defaulted to the Term SOFR plus a Benchmark Replacement Adjustment as recommended by the Relevant Governmental Body (all terms as defined in the Amended Credit Agreement).

On May 21, 2024, the Company amended the Term Loan Facility to, among other things, increase and extend the maturity date of the Term Loan Facility. The amendment increased the aggregate principal amount available from $388.0 million to $438.0 million, extended the maturity date from February 24, 2028 to February 25, 2030, decreased the interest rate margin to 2.25% over Term SOFR and removed the Benchmark Replacement Adjustment of 0.11%.

As of June 30, 2025, GCMH had borrowings of $433.6 million outstanding under the Term Loan Facility and no outstanding balance under the Revolving Credit Facility. As of June 30, 2025, we had available borrowing capacity of $50.0 million under our Revolving Credit Facility.

See Note 11 of our Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q for a summary of our outstanding indebtedness.

The terms of the Company's current debt instruments contain covenants that may restrict the Company and its subsidiaries from paying distributions to its members. As a holding company, we are dependent upon the ability of GCMH to make distributions to its members, including us. However, the ability of GCMH to make such distributions is subject to its operating results, cash requirements and financial condition, restrictive covenants in our debt instruments and applicable Delaware law. These restrictions include restrictions on the payment of distributions whenever the payment of such distributions would cause GCMH to no longer be in compliance with any of its financial covenants under the Term Loan Facility. Absent an event of default under the Credit Agreement governing the terms of the Term Loan Facility, GCMH may make unlimited distributions when the Total Leverage Ratio (as defined in the Credit Agreement) is below stated thresholds. As of June 30, 2025, the Total Leverage Ratio was below such stated thresholds and we were in compliance with all financial covenants.

See Note 12 of our Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q for a summary of our interest rate derivatives to hedge interest rate risk related to the Company's outstanding indebtedness.

**<u>Dividend Policy</u>**

We are a holding company with no material assets other than our indirect ownership of equity interests in GCMH and certain deferred tax assets. As such, we do not have any independent means of generating revenue. However, management of GCM Grosvenor expects to cause GCMH to make distributions to its members, including us, in an amount at least sufficient to allow us to pay all applicable taxes, to make payments under the tax receivable agreement, and to pay our corporate and other overhead expenses. On August 4, 2025, GCMG's Board of Directors declared a quarterly dividend of $0.11 per share of Class A common stock to record holders as of the close of business on September 2, 2025. The payment date will be September 16,

------

2025. The payment of cash dividends on shares of our Class A common stock in the future, in this amount or otherwise, will be within the discretion of GCMG's Board of Directors at such time.

**<u>Stock Repurchase Plan</u>**

On August 6, 2021, GCMG's Board of Directors authorized a stock repurchase plan which may be used to repurchase our outstanding Class A common stock and warrants to purchase Class A common stock. Our Class A common stock and warrants may be repurchased from time to time in open market transactions, in privately negotiated transactions, including with employees or otherwise, pursuant to the requirements of Rule 10b5-1 and Rule 10b-18 of the Exchange Act, as well as to retire (by cash settlement or the payment of tax withholding amounts upon net settlement) equity-based awards granted under our 2020 Incentive Award Plan, as amended and restated (and any successor plan thereto), with the terms and conditions of these repurchases depending on legal requirements, price, market and economic conditions and other factors. We are not obligated under the terms of the program to repurchase any of our Class A common stock or warrants, the program has no expiration date and we may suspend or terminate the program at any time without prior notice. Any shares of Class A common stock and any warrants repurchased as part of this program will be canceled. GCMG's Board of Directors has made subsequent increases to its stock repurchase authorization for shares and warrants. As of December 31, 2024, the total authorization was $140 million, excluding fees and expenses. On February 6, 2025, GCMG's Board of Directors increased the Company's existing share repurchase authorization by $50 million, from $140 million to $190 million. On August 4, 2025, GCMG's Board of Directors further increased the firm's existing repurchase authorization by $30 million, from $190 million to $220 million.

For the six months ended June 30, 2025, we spent $24.9 million to reduce Class A shares to be issued to employees, which reflects both RSUs that were settled in cash and shares retired in connection with the net share settlement of equity-based awards. Other than the deemed repurchases described above, no shares of Class A common stock or warrants were repurchased during the six months ended June 30, 2025. As of June 30, 2025, $57.2 million remained available under our stock repurchase plan.

We review our capital return plan on an on-going basis, considering our financial performance and liquidity position, investments required to execute our strategic plans and initiatives, acquisition opportunities, the economic outlook, regulatory changes and other relevant factors. As these factors may change over time, the actual amounts expended on repurchase activity, dividends, and acquisitions, if any, during any particular period cannot be predicted and may fluctuate from time to time.

**<u>Tax Receivable Agreement</u>**

Exchanges of Grosvenor common units by limited partners of GCMH result in increases in the tax basis in our share of the assets of GCMH and its subsidiaries that otherwise would not have been available. These increases in tax basis increase our depreciation and amortization deductions and create other tax benefits, and therefore may reduce the amount of tax that we would otherwise be required to pay in the future. The tax receivable agreement requires us to pay 85% of the amount of these and certain other tax benefits, if any, that we realize (or are deemed to realize in certain circumstances) to the TRA Parties. During the six months ended June 30, 2025, the conversion of 2,569,415 Partnership common units for 2,569,415 Class A common stock resulted in a step-up in tax basis under IRS §754. Any net tax benefits recognized because of this step-up will result in future tax benefit payments under the tax receivable agreement. The increase in the payable to related parties pursuant to the tax receivable agreement liability due to this exchange is approximately $9.0 million as of June 30, 2025. As of June 30, 2025, the amount payable to related parties pursuant to the tax receivable agreement was $60.6 million.

**Contractual Obligations, Commitments and Contingencies**

See Note 13 in the notes to the Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q for a summary of the lease payments. There are no other material changes outside of the ordinary course of business in our contractual obligations, commitments and contingencies from those disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

**Critical Accounting Policies and Estimates**

The preparation of our Condensed Consolidated Financial Statements requires us to make estimates that affect the reported amounts of assets, liabilities, revenue and expenses. We base our judgments on our historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making estimates about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

------

For a more complete discussion of the accounting judgments and estimates that we have identified as critical in the preparation of our Condensed Consolidated Financial Statements, please refer to Note 2 in the notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

Our critical accounting policies are more fully described under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. There have been no material changes to our risk factors since our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

**Recent Accounting Pronouncements**

Information regarding recent accounting developments and their impact on our results can be found in Note 2 in the notes to the Condensed Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

In the normal course of business, we are exposed to a broad range of risks inherent in the financial markets in which we participate, including price risk, interest-rate risk, access to and cost of financing risk, liquidity risk, counterparty risk and foreign exchange-rate risk. Potentially negative effects of these risks may be mitigated to a certain extent by those aspects of our investment approach, investment strategies, fundraising practices or other business activities that are designed to benefit, either in relative or absolute terms, from periods of economic weakness, tighter credit or financial market dislocations.

Our predominant exposure to market risk is related to our role as general partner or investment manager for our funds and the sensitivity to movements in the fair value of their investments, which may adversely affect our investment income, management fees, and incentive fees, as applicable.

Based on the floating rate component of our Term Loan Facility and excluding any impact of interest rate hedges as of June 30, 2025, we estimate that a 100 basis point increase in SOFR would result in increased interest expense of $4.3 million over the next 12 months.

There have been no material changes in our market risks during the six months ended June 30, 2025. For additional information, refer to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

**ITEM 4. CONTROLS AND PROCEDURES**

**Limitations on effectiveness of controls and procedures**

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

**Evaluation of disclosure controls and procedures**

Our management, with the participation of our principal executive officer and principal financial officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2025.

**Changes in internal control over financial reporting**

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II - OTHER INFORMATION**

------

**ITEM 1. LEGAL PROCEEDINGS**

From time to time, we are a defendant in various lawsuits related to our business. We do not believe that the outcome of any current litigation will have a material effect on our condensed consolidated statements of financial condition or statements of income (loss).

In the normal course of business, we may enter into contracts that contain a number of representations and warranties, which may provide for general or specific indemnifications. The Company's exposure under these contracts is not currently known, as any such exposure would be based on future claims, which could be made against us. We are not currently aware of any such pending claims and based on our experience, we believe the risk of loss related to these arrangements to be remote.

**ITEM 1A. RISK FACTORS**

There have been no material changes to our risk factors since our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** 

During the three months ended June 30, 2025, we did not purchase any shares of Class A common stock or warrants to purchase shares of Class A common stock. See Note 6 of our Condensed Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information about our stock repurchase plan.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Disclosure in lieu of reporting on a Current Report on Form 8-K.

None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Material changes to the procedures by which security holders may recommend nominees to the board of directors.

None.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Insider Trading Arrangements and Policies.

During the second quarter of 2025, none of the Company's directors or executive officers adopted or terminated a Rule 10b5-1 trading plan or a non-Rule 10b5-1 trading arrangement (as each term is defined in Item 408(c) of Regulation S-K).

------

**ITEM 6. EXHIBITS** 

The following is a list of exhibits filed as part of this Quarterly Report on Form 10-Q.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|<br>**Exhibit<br>Number** |<br>**Exhibit Description** | **Form** | **File No.** | **Exhibit** | **Filing<br>Date** | **Filed/**<br>**Furnished<br>Herewith** |
| 2.1† | <u>[Transaction Agreement, dated as of August 2, 2020, by and among CF Finance Acquisition Corp., CF Finance Intermediate Acquisition, LLC, CF Finance Holdings, LLC, Grosvenor Holdings, L.L.C., GCM Grosvenor Holdings, LLC, Grosvenor Capital Management Holdings, LLLP, GCM Grosvenor Management, LLC, Grosvenor Holdings II, L.L.C., GCMH GP, L.L.C., GCM V, LLC, and GCM Grosvenor Inc.](https://www.sec.gov/Archives/edgar/data/1728041/000121390020020009/ea124874ex2-1_cffinance.htm)</u> | 8-K/A | 001-38759 | 2.1 | 08/04/20 |  |
| 3.1 | <u>[Amended and Restated Certificate of Incorporation of GCM Grosvenor Inc.](https://www.sec.gov/Archives/edgar/data/1819796/000121390020038527/ea130282ex3-1_gcmgrosvenor.htm)</u> | 8-K | 001-39716 | 3.1 | 11/20/20 |  |
| 3.2 | <u>[Amended and Restated Bylaws of GCM Grosvenor Inc.](https://www.sec.gov/Archives/edgar/data/1819796/000121390020038527/ea130282ex3-2_gcmgrosvenor.htm)</u> | 8-K | 001-39716 | 3.2 | 11/20/20 |  |
| 4.1 | <u>[Warrant Agreement, dated December 12, 2018, between Continental Stock Transfer & Trust Company and CF Finance Acquisition Corp.](https://www.sec.gov/Archives/edgar/data/1728041/000161577418014531/s114716_ex4-1.htm)</u> | 8-K | 001-38759 | 4.1 | 12/17/18 |  |
| 10.1 | <u>[GCM Grosvenor Inc. Non-Employee Director Compensation Policy (effective as of April 1, 2025)](https://www.sec.gov/Archives/edgar/data/0001819796/000181979625000002/exhibit101q42024.htm)</u> | 8-K | 001-39716 | 10.1 | 2/10/25 |  |
| 10.2 | <u>[Share Purchase Agreement, dated April 14, 2025, between GCM Grosvenor Inc. and Sumitomo Mitsui Trust Bank, Limited](https://www.sec.gov/Archives/edgar/data/0001819796/000121390025031764/ea023731902ex10-1_gcmgros.htm)</u> | 8-K | 001-39716 | 10.1 | 4/15/25 |  |
| 31.1 | <u>[Chief Executive Officer Certifications pursuant to Section 302 of the Sarbanes Oxley Act of 2002](exhibit311q22025.htm)</u> |  |  |  |  | \* |
| 31.2 | <u>[Chief Financial Officer Certifications pursuant to Section 302 of the Sarbanes Oxley Act of 2002](exhibit312q22025.htm)</u> |  |  |  |  | \* |
| 32.1 | <u>[Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002](exhibit321q22025.htm)</u> |  |  |  |  | \*\* |
| 32.2 | <u>[Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002](exhibit322q22025.htm)</u> |  |  |  |  | \*\* |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  |  |  |  | \* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |  |  |  |  | \* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  |  | \* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  |  | \* |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  |  | \* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  |  | \* |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |  |  |  |  | \* |

---

____________

\* &nbsp;&nbsp;&nbsp;&nbsp;Filed herewith.

\*\* &nbsp;&nbsp;&nbsp;&nbsp;Furnished herewith.

†&nbsp;&nbsp;&nbsp;&nbsp;Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **GCM GROSVENOR INC.** | **GCM GROSVENOR INC.** |
| Date: August 7, 2025 | By: | /s/ Michael J. Sacks |
|  |  | Michael J. Sacks |
|  |  | Chief Executive Officer |
|  |  | *(Principal Executive Officer)* |

---

---

| | | |
|:---|:---|:---|
| | **GCM GROSVENOR INC.** | **GCM GROSVENOR INC.** |
| Date: August 7, 2025 | By: | /s/ Pamela L. Bentley |
|  |  | Pamela L. Bentley |
|  |  | Chief Financial Officer |
|  |  | *(Principal Financial Officer)* |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION** 

I, Michael J. Sacks, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of GCM Grosvenor Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | | |
|:---|:---|:---|
| Date: August 7, 2025 | By: | /s/ Michael J. Sacks |
|  |  | Michael J. Sacks |
|  |  | Chief Executive Officer<br>*(principal executive officer)* |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION** 

I, Pamela L. Bentley, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of GCM Grosvenor Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | | |
|:---|:---|:---|
| Date: August 7, 2025 | By: | /s/ Pamela L. Bentley |
|  |  | Pamela L. Bentley |
|  |  | Chief Financial Officer<br>(*principal financial officer)* |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of GCM Grosvenor Inc. (the "Company") for the period ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: August 7, 2025 | By: | /s/ Michael J. Sacks |
|  |  | Michael J. Sacks |
|  |  | Chief Executive Officer<br>*(principal executive officer)* |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report on Form 10-Q of GCM Grosvenor Inc. (the "Company") for the period ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: August 7, 2025 | By: | /s/ Pamela L. Bentley |
|  |  | Pamela L. Bentley |
|  |  | Chief Financial Officer<br>(*principal financial officer)* |

---

<br>